Analysis of Amino Acids Relevant to Activity and Substrate Specificity of the Human DNA Repair Protein 0-6-Methylguanine DNA Methyltransferase (MGMT) by Morgan, Susan Elizabeth
Loyola University Chicago 
Loyola eCommons 
Dissertations Theses and Dissertations 
1995 
Analysis of Amino Acids Relevant to Activity and Substrate 
Specificity of the Human DNA Repair Protein 0-6-Methylguanine 
DNA Methyltransferase (MGMT) 
Susan Elizabeth Morgan 
Loyola University Chicago 
Follow this and additional works at: https://ecommons.luc.edu/luc_diss 
 Part of the Molecular Biology Commons 
Recommended Citation 
Morgan, Susan Elizabeth, "Analysis of Amino Acids Relevant to Activity and Substrate Specificity of the 
Human DNA Repair Protein 0-6-Methylguanine DNA Methyltransferase (MGMT)" (1995). Dissertations. 
3383. 
https://ecommons.luc.edu/luc_diss/3383 
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. 
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more 
information, please contact ecommons@luc.edu. 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. 
Copyright © 1995 Susan Elizabeth Morgan 
~BRARY-LOYOLA l!NII/Vi .. ic.:1rv·1 I .......... ,' l-
~- MEDIC,t...L Cr!\•--~-,~. 
,;;_", " , __, -, L:! J ! t.(·J 
......... < ~- '-· ,, ':;, 
LOYOLA UNIVERSITY CHICAGO 
ANALYSIS OF AMINO ACIDS RELEVANT TO ACTIVITY AND SUBSTRATE 
SPECIFICITY OF THE HUMAN DNA REPAIR PROTEIN 
0-6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) 
A DISSERTATION SUBMITTED TO 
THE FACULTY OF THE GRADUATE SCHOOL 
IN CANDIDACY FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
GRADUATE PROGRAM IN MOLECULAR BIOLOGY 
BY 
SUSAN ELIZABETH MORGAN 
CHICAGO, ILLINOIS 
JANUARY, 1995 
Copyright by Susan E. Morgan, 1994 
All rights reserved 
ii 
ACKNOWLEDGEMENTS 
I would like to recognize the members of my committee 
for their helpful criticisms and assistance in developing a 
productive graduate school career: Dr. M. Eileen Dolan, Dr. 
Leonard C. Erickson, Dr. Mark R. Kelley, Dr. John M. Lopes, 
and my advisor Dr. Russell 0. Pieper. I would also like to 
thank Russ for his constant guidance, support, and 
dedication. I am grateful for the influence Russ has had on 
my scientific presentations, writing, and critical thinking. 
To my friends and laboratory colleagues, I also of fer my 
appreciation for their help and camaraderie: Dr. Joseph 
Costello, Dawn Graunke, Tanja Dubrovcic, Sonal Patel, and 
Janice Kerr. 
I would like to acknowledge all those who assisted me in 
the preparation of this dissertation. In particular, I thank 
Fran Jannece and Dee Miller for their patience and aid 
throughout my stay here at Loyola. 
Finally, I would like to extend special thanks to 
Christopher Lappe and to my parents, John and Carole Morgan. 
iii 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS 
LIST OF FIGURES . 
LIST OF TABLES 
LIST OF ABBREVIATIONS. 
ABSTRACT 
Chapter 
I. INTRODUCTION 
II. REVIEW OF THE RELATED LITERATURE 
A. DNA Alkylating Agents . . . . . . . 
B. O6 -Methylguanine DNA Methyltransferase 
(MGMT) . . . . . . . . . . . . . . . 
c. Escherichia coli Alkyltransferase (Ada) 
.. l ll 
vii 
• X 
xi 
xiv 
. . . 1 
• • • • 6 
. . 6 
. . . 10 
. . . 12 
D. MGMT and Ada Protein Structure and Function . 14 
E. MGMT and Ada Substrate Specificity . . . . . 
1. Differential repair of various sized 
0 6 -alkylguanine adducts by MGMT 
19 
and Ada • . . • . ••.•. 20 
2. Differential repair of 
0 4-methylthymine and 
0 6 -benzylguanine by MGMT 
and Ada • • . . . . 21 
III. MATERIALS AND METHODS 
A. Bacteria and Plasmids 
B. Cell Culture 
c. Generation of Full-Length, Truncated, and 
Chimeric MGMT and ada cDNAs by PCR 
25 
25 
25 
Amplification. . • • • . . . • . . . . 26 
iv 
Chapter Page 
D. Preparation of Competent Alkyltransferase 
E. 
F. 
G. 
H. 
I. 
J. 
Deficient E.coli Cells. . . . . . . . 33 
Subcloning of MGMT and ada cDNAs into a 
Bacterial Expression Vector. 
Isolation of GST-MGMT, GST-Ada, and 
GST-Chimeric Fusion Proteins 
from E.coli ......... . 
staining of SDS-Polyacrylamide Gels 
Protein Quantitation ..... 
Preparation and Labeling of an 18 bp 
0 6 -MG-Containing DNA Substrate 
Assay for Repair of 0 6 -MG in DNA .. 
33 
35 
37 
38 
K. Analysis of 0 6 -BG Repair Activity 
39 
42 
43 
45 
48 
L. Assay for Repair of 0 4 -MT in DNA 
IV. RESULTS 
A. Construction of Full-Length, Truncated, and 
Chimeric MGMT and Ada Fusion Proteins ... 48 
1. Construction of GST-MGMT, GST-Ada, 
and GST-chimeric bacterial 
expression vectors ....... 48 
2. Expression and isolation of 
GST-MGMT, GST-Ada, and GST-
chimeric fusion proteins .... 50 
B. The Role of the 28 Amino Acid Carboxyl-Terminal 
Tail in MGMT Activity, Temperature 
Sensitivity, and Substrate Specificity 60 
1. Repair of 0 6 -MG in DNA by control 
MGMT and carboxyl-terminal MGMT 
deletion proteins. . . . . . 60 
2. Quantitation of active MGMT and 
MGMT-C28 fusion proteins 65 
V 
chapter Page 
V. 
3. Effect of 28 amino acid carboxyl-
terminal tail deletion on the 
rate of MGMT-mediated repair of 
0 6 -MG-containing DNA at 4°C ... 67 
4. Effect of 28 amino acid carboxyl-
terminal tail deletion on the 
rate of MGMT-mediated repair of 
0 6 -MG-containing DNA at 3 7°C 69 
5. Effect of 28 amino acid carboxyl-
terminal tail deletion on the 
rate of MGMT-mediated repair 
of 0 6 -BG . . . . . . . . . . 72 
6. Repair of 0 6 -BG by ADA-MGMTTAIL 
fusion protein . . . . . . . 74 
C. Analysis of MGMT Amino Acids Required for the 
Repair of 0 6 -MG in DNA . . . . . . . . . . 7 5 
D. Analysis of MGMT Amino Acid Regions Involved 
in 0 6 -Benzylguanine Substrate Specificity 81 
1. Repair of 0 6 -MG in DNA by control 
MGMT, Ada, or MGMT-ADA and ADA-
MGMT chimeric fusion proteins .. 81 
2. Quantitation of active control 
and chimeric Ada and MGMT fusion 
proteins ............ 85 
3. Repair of 0 6 -BG by MGMT-ADA and ADA-
MGMT chimeric fusion proteins 89 
4. Repair of 0 6 -BG by MGMT-ADA-MGMT 
chimeric fusion proteins 91 
E. Comparison of Ada Amino Acid Regions Involved 
in 0 4 -Methylthymine Substrate Specificity 
to that of MGMT Amino Acid Regions 
Involved in 0 6 -Benzylguanine 
Substrate Specificity ........... 96 
DISCUSSION. 
LITERATURE CITED 
VITA 
. 102 
117 
. 131 
vi 
Figure 
1. 
2. 
3. 
LIST OF FIGURES 
Alkyltransferase sequence alignment .. 
Alkyltransferase sequence alignment . 
Specific sequence of the 
oligodeoxynucleotide probe 
4. PCR amplification of control and mutant MGMT 
Page 
15 
24 
41 
and ada cDNAs ........•..... 49 
5. 
6. 
7. 
8. 
9. 
Diagrams of the full-length, truncated, 
and chimeric MGMT and Ada fusion 
proteins and MGMT oligopeptides 
SDS-PAGE analysis of ada-ogt- whole cell 
sonicates containing either GST-MGMT 
or GST-Ada fusion proteins ..... 
SDS-PAGE analysis of ada-ogt- whole cell 
sonicates containing either MGMT-C35, 
MGMT-Nl8, or MGMT-N78 fusion proteins 
SDS-PAGE analysis of ada-ogt- whole cell 
sonicates containing either 
ADA-PCHRV-MGMT, MGMT-PCHRV-ADA, or 
ADA-MGMTTAIL fusion proteins . ... 
SDS-PAGE analysis of ada-ogt- whole cell 
sonicates containing MGMT and Ada 
chimeric fusion proteins ..... . 
51 
53 
54 
55 
57 
10. SOS-PAGE analysis of GST-affinity purified 
MGMT and Ada GST-fusion proteins ..... 58 
11. SOS-PAGE analysis of GST-affinity purified 
ADA-PCHRV-MGMT and MGMT-PCHRV-ADA 
GST-fusion proteins ........••. 59 
vii 
Figure Page 
12. SOS-PAGE analysis of GST-affinity purified 
MGMT-ADA-MGMT GST-fusion proteins .... bl 
13. Repair of 0 6 -MG in DNA by control and 
14. 
15. 
truncated MGMT and Ada fusion proteins 63 
Quantitation of control and 
mutant MGMT fusion proteins 
Effect of 28 aa carboxyl-terminal tail 
deletion on the rate of MGMT-mediated 
repair of 0 6 -MG-containing DNA at 4° 
66 
68 
16. Analysis of the temperature sensitivity of 
the MGMT-C28 mutant fusion protein .... 70 
17. Effect of 28 aa carboxyl-terminal tail 
deletion on the rate of MGMT-mediated 
repair of 0 6 -MG-containing DNA at 37°C 71 
18. Effect of 28 aa carboxyl-terminal tail 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
deletion on the rate of MGMT-mediated 
repair of 0 6 -BG . . . . . . . . . . . 73 
Analysis of repair of 0 6 -BG by the 
ADA-MGMTTAIL fusion protein 
Repair of 0 6 -MG in DNA by control 
and truncated MGMT fusion proteins 
and oligopeptides ...... . 
Repair of 0 6 -MG in DNA by control MGMT, 
Ada, or MGMT-PCHRV-ADA, and 
ADA-PCHRV-MGMT fusion proteins ... 
Repair of 0 6 -MG in DNA by ADA-LELS-MGMT 
chimeric fusion protein ..... . 
Repair of 0 6 -MG in DNA by MGMT-GLHE-ADA 
chimeric fusion protein .... 
Analysis of repair of 0 6 -BG by the 
MGMT-PCHRV-ADA and ADA-PCHRV-MGMT 
chimeric fusion proteins ..... 
Analysis of repair of 0 6 -BG by the 
ADA-LELS-MGMT and MGMT-GLHE-ADA 
chimeric fusion proteins .... 
viii 
76 
77 
84 
86 
87 
90 
92 
Figure 
26. Summary diagram of the construction of 
MGMT-ADA-MGMT chimeric proteins 
27. Repair of 0 6 -MG in DNA and 0 6 -BG by control 
MGMT, Ada, and MGMT-ADA-MGMT chimeric 
Page 
94 
fusion proteins . . . . . .... 95 
28. Summary diagram of MGMT aa regions 
potentially involved in MGMT-
mediated repair of 0 6 -BG .•.. 
29. Repair of 0 6 -MG in DNA by control MGMT, Ada, 
ADA-PCHRV-MGMT, or MGMT-PCHRV-ADA 
97 
fusion proteins . . . . . . . . • . • 101 
ix 
Table 
1. 
LIST OF TABLES 
Analysis of 0 6 -BG repair activity by control 
MGMT, Ada, or truncated MGMT fusion 
proteins and oligopeptides ...•.. 
2. Repair of 0 4 -MT in DNA by MGMT-PCHRV-ADA 
and ADA-PCHRV-MGMT chimeric fusion 
Page 
80 
proteins ..•.........•.... 100 
X 
A 
aa 
Asn 
bp 
BSA 
C 
C 
cDNA 
CENU 
Ci 
DNA 
dNTP 
dsDNA 
OTT 
EDTA 
g 
Glu 
GST 
h 
HEPES 
LIST OF ABBREVIATIONS 
adenine 
amino acid 
asparagine 
base pair 
bovine serum albumin 
carboxyl 
cysteine 
complementary deoxyribonucleic acid 
chloroethylnitrosourea(s) 
Curie 
deoxyribonucleic acid 
deoxynucleotide triphosphate 
double stranded deoxyribonucleic 
acid 
dithiothreitol 
ethylenediamine tetraacetic acid 
gram 
glutamine 
glutathione s-transferase 
hour(s) 
N-[2-hydroxyethyl]piperazine N-[2-
ethansulfonic acid] 
xi 
H 
HPLC 
HTH 
IPTG 
kb 
kDa 
LB 
M 
MES 
MGMT 
min 
ml 
MNNG 
MNU 
mol 
N 
nt 
0.D. 
p 
PAGE 
PBS 
PCR 
histidine 
high performance liquid 
cnromatography 
helix-turn-helix 
isopropyl-B-D-thio-galactosidase 
kilobases 
kilodalton 
Luria broth 
molar 
2-(N-Morpholino) Ethane Sulfonic 
Acid 
0-6-methylguanine DNA 
methyltransferase 
minute(s) 
milliliter 
N-methyl-N-nitro-N-nitrosoguanidine 
N-methyl-N-nitrosourea 
mole(s) 
amino 
nucleotide 
0 6 -benzylguanine 
0 6 -methylguanine 
0 4 -methylthymine 
optical density 
proline 
polyacrylamide gel electrophoresis 
phosphate buffered saline 
polymerase chain reaction 
xii 
R arginine 
RNA ribonucleic acid 
s second(s) 
sos sodium dodecyl sulfate 
T thymine 
TBE tr is-boric acid-EDTA 
TE tris-EDTA 
tRNA transfer RNA 
u units 
UV ultraviolet 
V volts 
V valine 
vol volumes 
X g times gravity 
xiii 
Susan E. Morgan 
Loyola University Chicago 
ANALYSIS OF AMINO ACIDS RELEVANT TO ACTIVITY AND SUBSTRATE 
SPECIFICITY OF THE HUMAN DNA REPAIR PROTEIN, O-6-
METHYLGUANINE DNA METHYLTRANSFERASE 
O6 -methylguanine DNA methyltransferase (MGMT) is a human 
DNA repair protein which removes O6 -methyl and O6-alkyl groups 
from the O6-position of guanine in DNA. Since these methyl 
and alkyl lesions are believed to be associated with 
carcinogenesis induced by a variety of environmental 
mutagens, as well as with cytotoxicity caused by 
chemotherapeutic chloroethylnitrosoureas, the study of MGMT 
protein structure and function are of significant value in 
prevention and treatment of the tumorigenic state. 
MGMT protein structure and function are best understood 
when compared to the Escherichia coli alkyltransferase, Ada. 
The human MGMT and E.coli Ada repair DNA adducts through a 
common mechanism involving the stoichiometric transfer of 
chloroethyl or alkyl groups from the O6 -position of guanine 
to a cysteine contained within the protein's highly conserved 
proline-cysteine-histidine-arginine-valine (PCHRV) acceptor 
xiv 
site. Despite the common repair mechanism among MGMT and 
Ada, these proteins exhibit differential substrate 
specificities. Specifically, only MGMT repairs the bulky 
lesion, 0 6 -benzylguanine (06 -BG) and only Ada efficiently 
repairs 0 4-methylthymine (04-MT) in DNA. It remains unclear, 
however, what divergent aa outside the PCHRV acceptor site 
discriminate between 0 4 -MT in DNA and 0 6 -BG. Additionally, 
the contribution of aa in alkyltransferase-mediated DNA 
repair is relatively unknown. The studies in this 
dissertation were therefore designed to systematically 
analyze the role of aa regions in alkyltransferase activity 
and substrate specificity by generating a series of full-
length, truncated, and chimeric MGMT and Ada GST-fusion 
proteins, and MGMT oligopeptides, and assessing the ability 
of the wildtype and mutant proteins to repair 0 6 -
methylguanine (06 -MG) and 04 -MT in DNA and 06 -BG. 
With regard to protein activity, aa located throughout 
nearly the entire protein are involved in MGMT-mediated 
repair of 0 6 -MG in DNA. The unique MGMT 28 aa carboxyl-
terminal tail, however, was not required for the repair of 
0 6 -MG in DNA or 0 6 -BG, although deletion of the tail 
reversibly inhibited the ability of MGMT to repair 0 6 -MG in 
DNA at 4°C. This carboxyl-terminal tail, while affecting 
activity at lower temperatures, may also comprise a separate 
functional domain that mediates non-repair related 
activities. 
xv 
With regard to substrate specificity, the unique ability 
of MGMT to interact with 0 6 -BG appears to reside in aa 
located amino-terminal to the PCHRV acceptor site while aa 
involved in Ada-selective repair of 0 4 -MT are located both 
amino- and carboxyl-terminal to the PCHRV acceptor site. 
These results suggest that different aa regions in MGMT and 
Ada define the overall substrate specificity of the proteins. 
xvi 
CHAPTER 1 
INTRODUCTION 
Cancer is a disease in which normal cell growth becomes 
deregulated, resulting in tumor formation. Human tumors 
usually develop in progressive stages, resulting finally in 
an invasive, metastasizing, malignant cancer (Cairns, 1985). 
Metastatic spread of malignancy is the primary cause of 
treatment failure and subsequent death in cancer patients 
(Cairns, 1985). Multiple epigenetic and environmental 
factors that interact over long periods of time are involved 
in the generation of a malignant cell suggesting that 
carcinogenesis is a multicausal, multistep process. 
Cytotoxic chemotherapy is one of the most effective 
treatments against a wide variety of human cancers. This 
type of chemotherapy involves the use of alkylating agents 
such as the chloroethylnitrosoureas (CENU). 
Chloroethylnitrosoureas constitute a clinically important 
group of chemotherapeutic alkylating agents that damage DNA 
at nucleophilic sites including the 0 6 -position of guanine 
(Tong et al., 1983) . The 0 6 -chloroethylguanine adduct is 
believed to mediate the cytotoxic potential of CENU as this 
adduct undergoes a slow intramolecular rearrangement to 
ultimately yield N-1 guanine, N-3 cytosine DNA interstrand 
2 
crosslinks that are lethal to rapidly dividing tumor cells 
(Brent, 1985) . 
The clinical utility of CENU as anti-cancer agents is 
limited due to the ability of approximately 80% of human 
tumor cell lines to repair the CENU-induced chloroethyl group 
adduct at the 0 6 -position of guanine in DNA thus preventing 
the formation of cytotoxic DNA interstrand crosslinks 
(Erickson et al., 1980a; Robins et al., 1983; Pegg and Dolan, 
1987; Smith and Brent, 1989). This resistance is conferred 
by a human DNA repair enzyme, 0 6 -methylguanine DNA 
methyltransferase (MGMT) (Pegg et al., 1982; Tano et al., 
1990; Mitra and Kaina, 1993). MGMT irreversibly transfers 
chloroethyl and alkyl group adducts from the 0 6 position of 
guanine in DNA to a cysteine acceptor site contained within 
it's primary structure (Pegg et al., 1983; von Wronski et 
al., 1991). This transfer returns the damaged DNA base to an 
unmodified state and permanently inactivates the protein 
(Mehta et al., 1981; Pegg et al., 1982). While most normal 
human tissues contain MGMT repair activity, approximately 20% 
of human tumor cell lines are deficient in MGMT activity and 
are thus much more sensitive to CENU-induced cytotoxicity 
(Day et al., 1980; D'Incalci et al., 1988). Studies 
developing enhanced cancer chemotherapy regimens, therefore, 
have been directed at depleting MGMT activity in MGMT-
expressing tumor cell lines. MGMT depletion strategies have 
involved the use of non-cytotoxic MGMT inhibitors such as 0 6 -
3 
methylguanine (06 -MG) or the free base guanine analogue, 0 6 -
benzylguanine (06 -BG), prior to CENU therapy. Since 0 6 -MG and 
0 6 -BG directly interact with and inactivate MGMT, these 
compounds have proven in the laboratory setting to enhance 
the cytotoxic potential of CENU in MGMT-expressing tumors 
(Dolan et al., 1985; Dolan et al., 1989; Dolan et al., 1990). 
It should be noted, however, that these compounds, while 
somewhat effective, may also increase the dose-limiting 
toxicity of CENU to the bone marrow (DeVita et al., 1965; 
Gerson et al., 1987) . This problem might be eliminated, 
however, by designing strategies involving transfection of 
bone marrow cells with genetically engineered inhibitor-
insensitive MGMT proteins preceding CENU-MGMT inhibitor 
therapy. The protection of normal but not tumor cells from 
CENU-induced cytotoxicity would provide a more effective 
chemotherapeutic strategy. The development of these proposed 
regimens, however, relies on the design of better MGMT 
inhibitors and novel MGMT proteins with altered substrate 
specificities, which in turn depends upon a better 
understanding of how the MGMT protein interacts with its DNA 
substrates. 
MGMT protein structure and function are best understood 
when compared to the Escherichia coli alkyltransferase, Ada. 
The human MGMT and E. coli Ada repair DNA through a common 
mechanism involving the transfer of chloroethyl or alkyl 
groups from the 0 6 -position of guanine to a cysteine 
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contained within the protein's conserved proline-cysteine-
histidine- arginine-valine (PCHRV) acceptor site (Pegg. and 
Byers, 1992). These five invariant aa are believed to be 
required for protein activity (Ling-Ling et al., 1992; Pegg, 
1990) while the contribution of aa outside the acceptor site 
in alkyltransferase-mediated 0 6 -alkylguanine repair is 
relatively unknown. Since MGMT and Ada share a high degree 
of aa sequence homology surrounding the PCHRV acceptor site, 
the possibility exists that these conserved sequences 
contribute 
function. 
to and are 
Although 
neccessary 
MGMT and 
for 
Ada 
alkyltransferase 
exhibit similar 
characteristics, these proteins also have different substrate 
specificities. Specifically, only MGMT repairs the bulky 
lesion, 0 6 -BG (Dolan et al., 1991; Pegg et al., 1993), and 
only Ada efficiently repairs 0 4 -MT in DNA (Dolan et al., 
1984; McCarthy et al., 1984). It remains unclear, however, 
what divergent aa outside the PCHRV acceptor site 
discriminate between 0 4 -MT in DNA and 0 6 -BG. In considering 
the aa that may play a role in both alkyltransferase activity 
and substrate specificity, a series of mutant MGMT and Ada 
proteins were generated and assessed for their ability to 
repair 0 6 -MG and 0 4 -MT in DNA and the free damaged base 0 6 -BG. 
The purpose of my dissertation research is to determine 
the relationship between MGMT protein structure and function. 
I have proposed two specific aims to examine this 
relationship: 
Aim 1: 
5 
To determine the role of human MGMT sequences 
other than the cysteine acceptor site in the repair of 0 6 -
methylguanine adducts in DNA. 
Aim 2: To identify human MGMT sequences that play a 
role in substrate specificity. 
The significance of the proposed studies is two fold. 
First, the identification of aa which contribute to MGMT 
activity and substrate specificity will contribute to an 
understanding of how MGMT functions. Second, identification 
of such functionally relevant regions of the protein could 
guide development of better MGMT inhibitors and 
therapeutically useful MGMT proteins which may ultimately 
help overcome the resistance of MGMT-expressing tumor cells 
to CENU, thus enhancing cancer chemotherapy. 
CHAPTER II 
REVIEW OF THE RELATED LITERATURE 
A. DNA Alkylating Agents 
Alkylating agents include potent environmental mutagens 
and carcinogens as well as anti-tumor compounds (Maher et 
al., 1990). These agents can react with nucleophilic groups 
on all four bases of DNA such as the exocyclic oxygens and 
endocyclic nitrogens as well as the sugar phosphates of the 
DNA backbone (Loveless, 1969; Singer, 1976) . The 
distribution of these adducts at various sites within DNA 
depends on the chemical structure of the alkylating agent and 
the alkyl group itself. DNA adducts arising from alkylating 
agents are relevant to humans mainly because of the 
widespread exposure to nitrosoamines in our diet (Lyon, 
1978), continuous environmental exposure to alkylating agents 
including tobacco smoke (Wynder and Hoffman, 1967), and the 
clinical utility of alkylating agents in cancer chemotherapy. 
Monofunctional DNA alkylating agents are some of the 
most potent and widespread mutagens and carcinogens known and 
include such compounds as N-methyl-N-nitro-N-nitrosoguanidine 
(MNNG), N-methyl-N-nitrosourea (MNU) and dimethylnitrosamine. 
6 
7 
These reactive compounds alkylate DNA to form a variety of 
adducts, predominantly methylations at the N7 -position of 
guanine, the N3 -position of adenine, the 0 6 -position of 
guanine, and phosphodiester oxygens (Lawley, 1976; Singer, 
1979). These compounds can also react with DNA to form 
lesser amounts of methylated pyrimidine nitrogens and oxygens 
including methylations at the 0 2 -position of thymine, the 0 4 -
position of thymine, and the 0 2 -position of cytosine (Lawley, 
1976; Singer, 1979). Although all of these DNA lesions are 
a potential source of mutation, numerous reports have 
indicated that alkylation at the 0 6 -position of guanine, and 
to a lesser extent the 0 4 -position of thymine, by these 
environmental agents is of particular importance for the 
induction of mutations and cancers (Loveless, 1969; Toorchen 
and Topal, 1983; Day et al., 1987; Day and Ullah, 1992) . 
During DNA replication, 0 4 -MT mispairs with guanine, 
resulting in a T:A to C:G transition (Preston et al., 1986), 
while 0 6 -MG preferentially pairs with thymine rather than 
cytosine resulting in a G:C to A:T transition mutation (Snow 
et al., 1984; Loechler et al., 1984; Preston et al., 1986). 
These mutagenic modifications can be lethal depending on 
whether the modification occurs at a site essential or non-
essential for protein or nucleic acid structure or function 
(Kumar et al., 1990). Some of these mutations may result in 
the activation of oncogenes thus inducing malignant 
transformation of cells (Kumar et al., 1990) . In particular, 
8 
studies have found that activation of the proto-oncogenes Ha-
ras or K-ras in rat mammary and esophageal tumors or mouse 
lung tumors induced by MNU occurs by means of a G:C to A:T 
transition at the guanine in the second base of codon 12 
(Sukumar et al., 1983; Zarbl et al., 1985; Inui et al., 
1994), consistent with the formation and persistance of 0 6 -MG 
at this site. 
The cytotoxicity of environmental alkylating agents is 
also attributed in part to the accumulation of 0 6 -MG pre-
mutagenic mispairings in DNA. Such accumulation of 0 6 -MG 
lesions is believed to cause abortive mismatch repair (Day 
and Ullah, 1992; Karran and Bignami, 1992; Branch et al., 
1993) and abnormal induction of intra-chromosomal homologous 
recombination thus leading to chromosomal aberrations (Maher 
et al., 1990; Rasouli-Nia et al., 1994). In the mismatch 
repair model, the 0 6 -MG:T pair is recognized by the mismatch 
correction system which initiates excision of the incorrect 
thymine residue. It has been suggested by Karran et al., 
1994, that the subsequent repair synthesis, which occurs in 
the strand opposite of the 0 6 -MG, inevitably fails owing to 
the inability of the repair system to find a perfect 
complementary match for 0 6 -MG. Thus, the mismatch repair 
system may initiate an abortive correction that results in a 
repair patch in the strand opposite 0 6 -MG (Karran and 
Bignami, 1992) Persistence of the 0 6 -MG lesions coupled 
with abortive mismatch repair may result in elevated DNA 
9 
strand breaks. DNA strand breaks persisting into the 
subsequent cell cycle can inhibit the initiation of . DNA 
replication and are linked to cell killing (Singer, 1979). 
In contrast to environmental DNA alkylating agents, 
bifunctional chemotherapeutic alkylating agents such as 
chloroethylnitrosoureas (CENU) are clinically important in 
the treatment of cancer. CENU are used singly and in 
combination with other chemotherapeutic agents in the therapy 
of a wide variety of human neoplasias including lymphomas, 
colon, lung, and brain cancers, and drug-resistant multiple 
myeloma (Salmon, 1976; D' Incalci et al., 1988). CENU 
spontaneously decompose under physiologic conditions to form 
a chloroethylating moiety and a carbamoylating moiety 
(Montgomery et al., 1967; Colvin et al., 1976) The 
chloroethylating moiety can alkylate DNA at numerous 
nucleophilic sites including the 0 6 -position of guanine (Tong 
et al., 1983). The 0 6 -chloroethyl group adducts on guanine 
are believed to be the lesions most relevant to the 
cytotoxicity induced by CENU (reviewed in Erickson, 1991) as 
these adducts undergo a slow intramolecular rearrangement to 
form initially a cyclized intermediate, 0 6 -N1 -ethanoguanine, 
and ultimately, through interaction with the cytosine on the 
complementary DNA strand, an N1 -guanine, N3 -cytosine DNA 
interstrand crosslink (Brent, 1985). DNA interstrand 
crosslink formation induced by CENU correlates well with the 
inhibition of DNA replication and RNA transcription 
10 
!Friedberg, 1985), the induction of G2 arrest, and subsequent 
tumor cell death (Gralla et al., 1987). 
B. 0 6 -Methylquanine DNA Methyltransferase (MGMT) 
The human DNA repair protein, 0 6 -methylguanine-DNA 
methyltransferase (MGMT), by means of its ability to repair 
CENU-induced 0 6 -guanine monoadducts prior to DNA interstrand 
crosslink formation, represents the primary means of cellular 
resistance to the cytotoxic effects of CENU (Erickson et al., 
1980; Pegg and Dolan, 1987; Smith and Brent, 1989). MGMT, 
acting as a 22 kDa monomer, stoichiometrically transfers 
alkyl and chloroethyl group adducts from the 0 6 -position of 
guanine in DNA to a cysteine residue in its structure, 
thereby repairing DNA lesions in a single step reaction (Pegg 
and Byers, 1992; Mitra and Kaina, 1993). The transfer 
reaction is irreversible, forming 8-methylcysteine in the 
protein and undamaged guanine in the DNA substrate (Mehta et 
al., 1981; Pegg et al., 1982). MGMT can also form covalent 
interactions with the CENU-induced cyclized intermediate 0 6 -
N1-ethanoguanine (Gonzaga et al., 1992). The number of 0 6 -
alkylguanine lesions that can be repaired is directly 
proportional to the number of intracellular MGMT molecules. 
While most normal human tissues contain MGMT repair activity, 
approximately 20% of human tumor cell lines are deficient in 
MGMT activity and are thus much more sensitive to CENU-
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induced cytotoxicity (Day et al., 1980; Erickson et al., 
1980a; D'Incalci et al., 1988). Cell lines deficient in MGMT 
become resistant, however, to the cytotoxic effects of 
alkylating agents when a bacterial methyltransferase gene 
(ada) or the MGMT cDNA is transfected and appropriately 
expressed (Kataoka et al., 1986; Samson et al., 1986). These 
findings and others (Ewing and Kohn, 1978; Erickson et al., 
1980; Erickson et al., 1980a) establish a dominant role for 
MGMT in conferring CENU resistance and, in combination with 
other studies (Futscher et al., 1989; Dolan et al., 1990; 
Marathi et al., 1993), demonstrate the usefullness of 
inhibiting MGMT for therapeutic benefit. 
The cloning of the human MGMT cDNA (Tano et al., 1990; 
Hayakawa et al., 1990; Rydberg et al., 1990) has offered the 
opportunity to express and isolate MGMT in sufficient amounts 
for detailed biochemical analyses. The MGMT cDNA was first 
isolated by transforming alkyltransferase deficient bacteria 
with a cDNA library-made from an MGMT-expressing cell line, 
followed by phenotypic rescue of repair proficient cells in 
media containing MNNG (Tano et al., 1990) . The protein 
sequence encoded by the MGMT cDNA consists of 207 aa and has 
a predicted molecular weight of about 22 kDa (Bhattacharyya 
et al., 1990). There is no evidence of a nuclear 
localization sequence although MGMT has been found to be 
localized exclusively in the nucleus (Ayi et al., 1992; 
Ishibashi et al., 1994) and is chromatin-bound (Boulden et 
al., 1987) . MGMT requires 
modifications or cofactors, has 
approximately 7.7-8.5 (Pegg et al., 
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no post-translational 
an optimal pH of 
1983; Boulden et al., 
1987), and is strongly inhibited by high salt concentrations 
(Bhattacharyya et al., 1990) and metal ions (Scicchitano and 
Pegg, 1987). In addition to the human MGMT, 
alkyltransferases from yeast (Xiao et al., 1991), rat (Potter 
et al., 1991), mouse (Santibanez-Koref et al., 1992), hamster 
(Rafferty et al., 1992), rabbit (Iyama et al., 1994), E.coli 
(Ada, ogt) (Demple et al., 1985; Potter et al., 1987) and 
Bacillus subtilis (dat) (Kodama et al., 1989) have all been 
isolated. The E. coli Ada protein, as discussed below, was 
the first to be isolated and extensively characterized 
(Demple et al., 1985). 
C. Escherichia coli Alkyltransferase (Ada} 
The 3 9 kDa Ada protein contains two independent DNA 
repair domains separated by a protease-sensitive hinge region 
(Jeggo, 1979; Demple et al., 1982). The 39 kDa Ada protein 
can be proteolytically cleaved at this hinge region (located 
between lysine-178 and glutamine-179) (Teo et al., 1984; 
Demple, 1990) to yield a 19 kDa carboxyl-terminal fragment 
which repairs 0 6 -alkylguanine and 0 4 -alkylthymine adducts, and 
an amino-terminal fragment containing a second cysteine 
acceptor site which repairs alkylphosphotriesters (Demple and 
.. 
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Karran, 1983; Demple et al., 1985; Sedgwick et al., 1988). 
It is the repair of alkylphosphotriesters by the amino-
terminal domain that converts the 39 kDa alkyltransferase 
into a strong activator of ada gene transcription by enhanced 
binding of the 39 kDa protein to the ada gene promoter region 
(Nakabeppu and Sekiguchi, 1986). This phenomenon, known as 
the adaptive response (which can also be down-regulated by 
proteolytic cleavage of the hinge region, Akimaru et al., 
1990), provides an efficient system that allows bacteria to 
respond to DNA damage (Demple, 1986; Lindahl and Sedgwick, 
1988; Shevell et al., 1990) caused by a wide variety of 
alkylating agents including endogenously produced N-nitroso 
compounds (Tsimis and Yarosh, 1990; Vaughan et al., 1991). 
Ada, therefore, not only repairs alkylated DNA bases and DNA 
phosphotriesters but also plays a role in transcriptional 
regulation of the ada gene. 
In addition to the Ada protein, E. coli also contains a 
smaller methyltransferase encoded by the ogt gene. The 19 
kDa ogt protein repairs 0 6 -alkylguanine and 0 4 -alkylthymine 
lesions and shares limited aa sequence homology to the 
carboxyl-terminal domain of the Ada protein (Potter et al., 
1987; Wilkinson et al., 1989). Unlike Ada, which is 
inducible in response to alkylating agents, the ogt gene 
product is constitutively expressed and, in un-induced 
bacterial cells, provides the majority of the 
alkyltransferase activity (Rebeck et al., 1988; Shevell et 
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aI., 1988; Rebeck et al., 1989) The ogt protein thus 
serves to counteract low-level 0 6 -MG production in the 
bacterial genome (Potter et al., 1987). 
D. MGMT and Ada Protein Structure and Function 
All of the prokaryotic and eukaryotic alkyltransferases 
described to date share a high degree of primary aa homology 
(Santibanez-Koref et al., 1992; Moore et al., 1994) 
1) which suggests that the proteins not only 
(Figure 
may be 
structurally similar but may also share a common DNA repair 
mechanism. Such a common repair mechanism has been defined 
for all alkyltransferases in which DNA repair involves the 
transfer of alkyl groups from the 0 6 -position of guanine 
(and, in the case of Ada, the 0 4 -position of thymine) to a 
cysteine contained within the invariant proline-cysteine-
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initially demonstrated in studies in which MGMT and Ada were 
reacted with radiolabeled alkylated DNA. In each case, the 
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Additionally, in site-directed mutagenesis studies, 
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Figure 1. Alkyltransferase sequence alignment. Escherichia 
coli Ada (Demple et al., 1985), S. typhimurium adaC (Rebeck 
et al., 1989), B. subtillus adaB (Moore et al., 1994), B. 
subtillus datl (Kodama et al., 1989), E. coli ogt (Potter et 
al., 1987) mouse (Santibanez-Koref et al., 1992), rat (Potter 
et al., 1991), hamster (Rafferty et al., 1992), human (Tano 
et al., 1990), and yeast (Xiao et al., 1991) 
alkyltransferases share a high degree of aa sequence homology 
(bordered by two large arrows) surrounding the protein's 
PCHRV acceptor site (bordered by two small arrows). 
Identical aa are typed in bold. 
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with any of ten different aa (Ling-Ling et al., 1992), 
resulted in an alkyltransferase-negative phenotype. 
Furthermore, when the cysteine and histidine positions were 
inverted within the PCHRV acceptor site, alkyltransferase 
function was lost. These studies indicate that the exact 
position of cysteine within the acceptor site is critical for 
alkyltransferase function. In addition to cysteine, three 
other aa (P, H, and V) within the PCHRV acceptor site have 
also been suggested to be important for activity (Ling-Ling 
et al., 1992; Pegg and Byers, 1992). The contribution of 
these aa to repair is unproven although studies suggest that 
praline may serve to bend the protein in such a way as to 
properly orient the acceptor cysteine while the histidine and 
valine may play roles in proper protein folding and stability 
(Ling-Ling et al., 1992) . Amino acids outside the PCHRV 
acceptor site are also suggested to be important for repair 
activity as demonstrated by the presence of several invariant 
aa surrounding the cysteine acceptor site in all 
alkyltransferases (Figure 1) and by site-directed MGMT 
mutagenesis studies in which aa substitutions at some of 
these invariant aa, including asparagine 137 (Pieper et al., 
1994) and glutamic acid 172 (Rafferty et al., 1994), resulted 
in loss of activity. The importance of the PCHRV acceptor 
site and other surrounding conserved aa in alkyltransferase 
repair has been recently highlighted by crystallographic 
analysis of the 19 kDa carboxyl-terminal fragment of Ada 
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(Moore et al., 1994). Studies on the Ada crystal structure 
suggest that a histidine residue within PCHRV interacts with 
the acceptor cysteine and serves as a proton acceptor, 
generating a reactive cysteine thiolate anion that 
sequentially attacks, removes, and accepts alkyl lesions from 
the 0 6 -position of guanine in DNA. The formation and 
stabilization of this anion are believed to be facilitated by 
invariant aa contained within the highly conserved carboxyl-
terminal 85 aa region surrounding the PCHRV acceptor site. 
All of these studies therefore suggest that an understanding 
of aa involved in MGMT activity requires an analysis of aa 
beyond those directly involved in alkyl group transfer. 
In addition to sharing a common acceptor site and DNA 
repair mechanism, MGMT and Ada also share a strong preference 
for double stranded 0 6 -MG-containing oligodeoxynucleotide 
substrates greater than 12 bp (Scicchitano et al., 1986). In 
vitro studies concerning the polynucleotide requirements for 
alkyltransferase-mediated 0 6 -MG repair indicate that by far 
dsDNA in the B-conformation, as opposed to the z-
conformation, is the best substrate, whereas 0 6 -MG-containing 
RNA is a much poorer substrate (Lindahl et al., 1982; Harris 
et al., 1983; Boiteaux and Laval, 1985; Pegg et al., 1988). 
With regard to the repair of various lengths of 0 6 -MG-
containing oligodeoxynucleotide substrates, the rates of Ada-
and MGMT-mediated 0 6 -MG removal increase with increasing 
length of the substrate (i.e. rate of repair of 
dodecadeoxynucleotide> 
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hexadeoxynucleotide> 
tetradeoxynucleotide> free base) (Scicchitano et al., 1986; 
Graves et al., 1987; Dolan et al., 1988a), suggesting that 
the overall primary structure of dsDNA plays a vital role in 
the recognition and DNA repair processes. The finding that 
DNA binding may be important for alkyltransferase function is 
supported by the fact that 0 6 -MG as a free base is an 
approximately 10 7 -fold poorer substrate than 0 6 -MG in duplex 
DNA (Dolan et al., 1985; Yarosh et al., 1986). These large 
differences in affinities are explained by circular dichroism 
and fluorescence analyses which examined Ada- and MGMT-DNA 
interactions (Takahaski et al., 1990; Chan et al., 1993). 
These studies suggested that MGMT and Ada are activated by a 
conformational change induced by binding of the protein to 
damaged DNA and that this binding to DNA is the rate 
determining step in the transfer of alkyl groups to MGMT or 
Ada (Takahaski et al., 1990; Chan et al., 1993). 
Specifically, Ada, which has a ten times higher DNA binding 
affinity (Takahaski et al., 1990), repairs 0 6 -MG in DNA at a 
significantly faster rate than the human MGMT protein. On 
the other hand, the repair of radiolabeled 0 6 -MG containing 
DNA by either Ada or MGMT was only slightly inhibited by the 
addition of a 1000-fold excess of non-alkylated or alkylated 
DNA, suggesting that DNA binding may only play a small role 
in alkyltransferase activity (Graves et al., 1989). 
Nonetheless, a variety of studies have demonstrated that 
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alkyltransferases do have the capacity for high affinity DNA-
binding and will interact with DNA irrespective of the 0 6 -MG 
content (Bhattacharyya, et al., 1990; Pegg, 1990) , suggesting 
that the alkyl group accepting site may be distinct from a 
possible DNA binding domain. The region of the protein 
responsible for DNA binding, however, has not been defined 
al though there exist several aa regions surrounding the 
cysteine acceptor site that are rich in basic amino acids and 
thus are believed to be involved in DNA interaction (Pegg and 
Byers, 1992). 
E. MGMT and Ada Substrate Specificity 
An understanding of the similarities in alkyltransferase 
structure and function, however, does not explain the 
dramatically different abilities of alkyltransferases to 
interact with various types of DNA lesions. One may 
understand how alkyltransferases interact with distinct 
lesions by comparing the substrate specificities of the human 
MGMT to that of the E.coli Ada. The substrate specificities 
of MGMT and Ada are reviewed below with respect to the 
protein's relative preference for different sized alkyl 
groups at the 0 6 -position of guanine in DNA and the ability 
of the proteins to repair 0 6 -BG and 0 4 -MT. 
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1. Differential repair of various sized 0 6 -alkylguanine 
adducts by MGMT and Ada 
While 0 6 -MG in DNA is the preferred substrate, MGMT and 
Ada can also repair larger-sized alkyl groups at the 0 6 -
position of guanine but at rates of reaction that decrease 
dramatically as the alkyl group size increases (following the 
sequence: methyl> ethyl, n-propyl> n-butyl>> isopropyl, 
isobutyl, 2-hydroxyethyl). The repair of branched chain 
groups is much slower than that of linear alkyl groups 
(Morimoto et al., 1985; Pegg et al., 1985; Graves et al., 
1989) . Two main differences exist between MGMT and Ada in 
the rates of repair of these various sized alkyl groups at 
the 0 6 -position of guanine in DNA. First, MGMT repairs 0 6 -MG 
in DNA at a much lower rate than Ada (Bhattacharrya et al., 
1988). Second, the difference between the relative rates of 
repair for 0 6 -MG and longer alkyl groups is much greater for 
Ada (amounting to a 1000-fold difference) than for the MGMT 
protein (Morimoto et al., 1985; Pegg et al., 1985; Lindahl 
and Sedgwick, 1988; Demple, 1990; Pegg, 1990). These 
differences in repair rates for larger-sized alkyl groups for 
both MGMT and Ada could be due to steric constraints in which 
the larger substrates may prevent access of the cysteine 
acceptor site of the protein to the oxygen-linked carbon of 
guanine. Alternatively, Pegg and Byers (1992) suggest that 
the ethyl and larger groups on the 0 6 -position of guanine may 
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adopt a novel conformation and be directed into the major 
groove of DNA in such a way that impedes DNA repair. Bul.ky, 
branched-chain adducts such as 0 6 -isobutylguanine that 
distort the DNA helix, and act as DNA replication blocks, are 
believed to be removed by the excision repair pathway (Samson 
et al., 1988; Pegg and Byers, 1992). 
2. Differential repair of 0 4 -methylthymine and 0 6 -
benzylguanine by MGMT and Ada 
One may further define how alkyltransferases interact 
with distinct lesions by comparing the abilities of MGMT and 
Ada to repair 0 4 -MT in DNA, and the free base 0 6 -BG. Ada 
efficiently repairs in a dodecadeoxynucleotide 
substrate, or in poly d (A) -d (T) , whereas MGMT-mediated repair 
of this lesion is absent (McCarthy et al., 1984; Dolan et 
al. , 1984) . Several studies suggest, however, that if a 
1000-fold molar excess of MGMT protein is used, repair of 0 4 -
MT-containing DNA in vitro is detectable (Koike et al., 1990; 
Sassanfar et al., 1991). This repair, however, occurs more 
slowly than MGMT-mediated repair of 0 6 -MG in DNA (Becker and 
Montesano, 1985; Brent et al., 1988; Dolan et al., 1988). 
The rate of repair of 0 4 -MT in DNA by MGMT is at least 10,000 
times lower than the repair of 0 6 -MG in DNA (O'Toole et al., 
1993) . The extremely poor reactivity of MGMT toward 0 4 -MT 
makes it unlikely that this repair reaction occurs to any 
significant extent in human cells exposed to alkylating 
22 
agents, and the general consensus from in vitro and in vivo 
studies has been that MGMT does not 
(Belinsky et al., 1986; Brent et al., 
repair 0 4 -MT in _DNA 
1988; Hall et al., 
1990; Pegg and Byers, 1992). An alternative pathway for 0 4 -
MT repair has been detected in mammalian cells, but this 
repair activity has not been well characterized (Wani et al., 
1990) . MGMT and Ada are further distinguished by their 
differential sensitivities to 0 6 -BG. Only MGMT repairs 0 6 -BG, 
a guanine analog which was developed as a non-cytotoxic MGMT 
depleting agent (Pegg, 1990; Dolan et al., 1991; Pegg et al., 
1993) . 0 6 -BG is an excellent substrate, serving as an 
effective inactivator of MGMT (Dolan et al., 1990). This 
potent agent has thus been used by several groups (Dolan et 
al., 1990; Marathi et al., 1993) to markedly enhance the 
cytotoxic effects of chloroethylating agents toward MGMT-
expressing human tumor cells. As mentioned above, the rate 
of MGMT-mediated repair of DNA adducts decreases as the alkyl 
group size increases, indicating that steric constraints 
limit the reaction. In the case of 0 6 -BG, however, the 
steric hindrance is offset by the greater ability of the 
benzene ring to delocalize charge in the transition state for 
a displacement reaction (Dolan et al., 1990). The Ada 
protein, however, may be more sterically hindered by the 
benzene ring suggesting that subtle differences in protein 
conformation around the protein's active site may be critical 
in allowing the interaction between the alkyltransferase and 
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larger-sized substrates such as 0 6 -BG (Dolan et al., 1991). 
It remains unclear which part of the protein, or which 
aa, discriminate between 0 4 -MT in DNA and 0 6 -BG. The basis 
for differential substrate specificities, however, clearly 
resides outside the protein's shared PCHRV acceptor site, and 
may lie in subtle differences in the protein's primary aa 
sequence. Two major structural differences between MGMT and 
Ada include a highly divergent amino-terminal 75 aa segment, 
and a MGMT 28 aa carboxyl-terminal tail (Figure 2). This 
carboxyl-terminal extension is highly conserved among human, 
rat, mouse, and hamster alkyltransferases but is absent in 
yeast and bacterial alkyltransferases such as E. coli Ada, 
ogt and B. subtilis dat. Divergent aa or aa regions, while 
of unknown function, may contribute to the differences in 
MGMT-mediated repair of 0 6 -BG and Ada-mediated repair of 0 4 -
MT. 
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PILIPCHRV rRSOGAIGIIYSGGGQTVICE.liLLAr."EG r PTGQPA. SKGLGL [GSWLKPSFESSSPKPSG 
PILIPCBRVICSNGSIGNYSGGGQAVlfE:I-ILLAh~GIPTRQPA.CKDLGLTGTRLKPSGGSTSSKLSG 
PILIPCHllVVCSSGAVGNYS.GGLAVJ\'EWLLAh'EGHRLGKPGLGGSSGLAGAWLKGAGATSGSPPAGRN 
ALL\/PCHRIVGSNRKL TGYKWS. CKLKE~LL,'l.",l:l'EllSLSLSRL 
-------------
Figure 2. Alkyltransferase sequence alignment. Escherichia 
coli Ada (Demple et al., 1985), S. typhimurium adaC (Rebeck 
et al., 1989), B. subtillus adaB (Moore et al., 1994), B. 
subtillus datl (Kodama et al., 1989), E. coli ogt (Potter et 
al., 1987) mouse (Santibanez-Koref et al., 1992), rat (Potter 
et al., 1991), hamster (Rafferty et al., 1992), human (Tano 
et al., 1990), and yeast (Xiao et al., 1991) 
alkyltransferases exhibit two main structural differences. 
These two differences include an amino-terminal 75 aa segment 
(bordered by two arrows) which is relatively non-conserved 
between proteins, and a 28 aa carboxyl-terminal tail 
(designated by solid lines) which is highly conserved only 
among mouse, rat, hamster, and human alkyltransferases. 
Identical aa are typed in bold. Alignment of the numbered aa 
is according to Moore et al., 1994. 
CHAPTER III 
MATERIALS AND METHODS 
A. Bacteria and Plasmids 
E. coli strain GWRlll [(ada--alkB) ,kan+, ogt-] was used 
as a methyltransferase deficient host cell and was provided 
by Dr. B. Demple (Rebeck and Samson, 1991) The plasmid, 
pGEX-3X (Pharmacia LKB; Uppsala, Sweden), was used as a 
prokaryotic expression vector. This plasmid contains the GST 
gene from S. japonicum which encodes a 26 kDa protein. The 
GST protein is fused to the protein products of coding 
sequences inserted into the multiple cloning site. Between 
the GST gene and the cDNA inserts, a recognition sequence for 
a site-specific protease (factor Xa) is encoded. The 
expression vector directs the synthesis of GST fusion 
proteins in E. coli under the control of the IPTG-inducible 
tac promoter. 
B. Cell Culture 
The HT-29 colon carcinoma cell line was obtained from 
Dr. L. Erickson and was cultured in Eagle's minimum essential 
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medium supplemented with 10% bovine calf serum, glutamine, 
sodium pyruvate, vitamin B12, nonessential amino acids, _and 
gentamicin. Cultures were incubated at 37°C in a 95% air, 5% 
CO2 atmosphere. 
c. Generation of Full-Length, Truncated, and Chimeric MGMT 
and ada cDNAs by PCR Amplification 
Plasmid DNA containing a 721bp human MGMT cDNA (Tano et 
al., 1990) or a 2.3kb ada-alkB operon (Demple et al., 1985) 
was digested with HindIII (l0U/µg DNA, 2h, 37°C) and used as 
template in PCR amplification reactions. Full-length and 
truncated MGMT and ada cDNAs were generated using the 
following reaction conditions: DNA templates (1 µg) were 
added to a 100µ1 total volume solution containing lX PCR 
buffer (l0mM Tris-HCl pH 8.3, 50mM KCl, 2.5mM MgC1 2 , 0.01% 
gelatin), and 200 µMeach of dCTP, dATP, dGTP, and dTTP. To 
the mixture were added 50 pmol each of two synthetic 
oligonucleotides complementary either to the human MGMT cDNA 
or to the E. coli. ada DNA. 
CGTGGGATCCCCATGGACAAGGATTGTGA-3'), 
Primers prl 
nterm18 
CGTGGGATCCCCCTGGAGCTGTCTGGTTG-3'), and nterm78 
( 5' -
( 5' -
( 5' -
CGTGGGATCCCCTTCCCCGTGCCGGCTCTTCA-3') are complementary to 
different regions of the 5' end of the non-transcribed strand 
of the human MGMT cDNA. Each primer contains 12 non MGMT-
complementary nt at its 5' end which encode a recognition 
sequence for BamHl. Primers pr2 (5'-CGATGAATTCTCAGTT 
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TCGGCCAGCAG-3'), cterml0 (5'-CGATGAATTCTCAAGCTCCCGCTC 
CCTTGAGCCA-3'), cterm28 (5'-CGATGAATTCTCACAACCGGTGGCCTTCAT-
3 ' ) ' cterm35 (5'-CGATGAATTCTCATTCATGGGCCAGAAG-3'), and 
cterm65 (5'-CGATGAATTCTCAGATGAGGATGGGGACAGGATT-3') are 
complementary to different regions of the 3' end of the 
transcribed strand of the human MGMT cDNA. Each primer 
contains 13 non MGMT-complementary nt at its 5' end which 
encode a stop codon and an EcoRl restriction site. Primer 
adaup (5'-CGTGGGATCCCCATGCAATTCCGTCACGGTGGC-3') is 
complementary to the 5' end of the nontranscribed strand of 
the E. coli ada DNA sequence and contains 15 non-ada-
complementary nt which encode a recognition sequence for 
BamHl. Primer adadn (5'-CGATGAATTCTTACCTCTCCTCATTTTCAG-3') 
is complementary to the 3' end of the transcribed E.coli ada 
DNA sequence and contains 13 non-ada-complementary nt which 
encode a stop codon and an EcoRI restriction site. Taq DNA 
polymerase (2U; Perkin Elmer Cetus,Corp., Norwalk, CT.) was 
added to the PCR reaction and DNA amplification was performed 
for 20 cycles in a DNA thermal cycler (Perkin Elmer Cetus; 
denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and 
extension at 72°C for 45 s for each cycle). After 
amplification, 10 µl of each PCR reaction mixture were 
fractionated by electrophoresis (75 V, 30 min) along with a 
molecular weight marker in a 1% agarose gel (Seakem GTG, FMC, 
Rockland, ME) to confirm the size of the amplification 
products. Primers prl-pr2 amplify a 645-bp cDNA sequence 
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which encodes a full-length MGMT protein (MGMT). Primers 
nterml8-pr2 amplify a 567-bp MGMT cDNA fragment which 
encodes a protein (MGMT-Nl8) lacking 18 aa from the amino-
terminus. Primers nterm78-pr2 amplify a 387-bp MGMT cDNA 
fragment which encodes a protein (MGMT-N78) lacking 78 aa 
from the amino-terminus. Primers prl-cterml0 amplify a 621-bp 
MGMT cDNA fragment which encodes a protein (MGMT-Cl0) which 
lacks 10 aa from the carboxyl-terminus. Primers prl-cterm28 
amplify a 549-bp MGMT cDNA fragment which encodes a protein 
(MGMT-C28) lacking the 28 aa carboxyl-terminal tail. Primers 
prl and cterm35 amplify a 516-bp cDNA sequence which encodes 
a protein (MGMT-C35) lacking 35 aa from the carboxyl-terminal 
end. Primers prl-m2 amplify a 450 bp MGMT cDNA fragment 
which encodes a protein (MGMT-C65) lacking 65 aa (including 
the PCHRV acceptor site) from the carboxyl-terminus. Primers 
adaup-adadn amplify a 553-bp DNA fragment which encodes an 
active 19kDa alkyltransferase carboxyl-terminal domain (Ada) 
which is part of the larger 39kDa E. coli Ada protein. 
All MGMT-ada, ada-MGMT, and MGMT-ada-MGMT chimeric cDNAs 
were generated using the PCR overlap extension technique. 
PCR amplification of each half of the MGMT-ada and ada-MGMT 
cDNAs was performed separately, followed by joining of the 
halves in a third PCR reaction (Ho et al., 198 9) . For 
generation of each half of MGMT-ada chimeric cDNAs, 
linearized plasmid containing MGMT or ada cDNAs was amplified 
using two primers complementary either to the MGMT cDNA or to 
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the ada DNA. MGMT cDNA complementary primers were prl 
(described above), chim3 (5'-TACCCGATGACAGGGGATGAGGATGGG~3') 
or 3glhe (5' -ATCATCGCCCAGCAACTTTATTTCGTGCAG-3'). Ada DNA 
complementary primers were adadn (described above), chim4 
(5'-CCCTGTCATCGGGTAGTACGCGGTG-3'), or 5glhe (5'-
TTGCTGGGCGATGATGACGCCACATTA-3'). Primers chim4 and 5glhe 
contain at their 5' ends 15nt complementary to chim3 and 
Jglhe primers, respectively. For amplification of each half 
of ada-MGMT chimeric cDNAs, primers complementary either to 
the ada DNA or the MGMT cDNA were used. Ada DNA complementary 
primers were adaup (described above), chiml (5'-
TCCGCTGCTGCAGACTACCCGATGACAGGGTAT-3'), tailada (5'-CCT 
CTCCTCATTTTCAGCTTCG-3') or 3lelsg (5'-ACCAGACAGCTCCAGACG 
ACCCAGCTCACAAT-3') . MGMT cDNA complementary primers were pr2 
(described above), chim2 (5'-GTCTGCAGCAGCGGAGCCGTGGGCAA-3'), 
tailmgmt (5'-GCTGAAAATGAGGAGAGGCCAGGCTTGGGAGGG-3') or 5lelsg 
(5'-CTGGAGCTGTCTGGTTGTGAGCAGGGT-3'). Primers chim2, 
tailmgmt, and 5lelsg contain at their 5' ends 15 nt 
complementary to chiml, tailada, and 3lelsg primers, 
respectively. For generation of the MGMT-ada-MGMT chimeric 
cDNAs, overlapping MGMT-ada and ada-MGMT cDNA fragments were 
PCR amplified separately followed by joining of the halves in 
a third PCR reaction. For generation of the first half of 
MGMT-ada-MGMT cDNAs (MGMT-ada cDNA fragment), linearized 
plasmid containing MGMT cDNA was amplified using two primers 
complementary to the MGMT cDNA. Primers used were prl 
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(described above), 3-regl (5'-GCCGATGGCGTTAGCTAATTGCTGGT 
AAGAAATCACTTC-3'), 3-reg2 (5'-GCGCAGTGCCTGCCATAACACC 
TGTCTGGTGAA-3'), 3-reg3 (5'-GCGAATGTCCAGCGGGAACTCTTC 
GATAGCCTC-3'), 3-reg4 (5'-GCTGGCGATCACTTCCCAGGCTGTGCACTGCAT-
3'), or 3-regS (5'-ATCATCGCCCAGCAACTTTATTTCGTGCAGACC-3'). 
For generation of the second half of MGMT-ada-MGMT cDNAs 
(ada-MGMT cDNA fragment), linearized plasmid containing MGMT 
cDNA was amplified using two primers complementary to the 
MGMT cDNA. Primers used were 5-regl (5'-GCTAACGCCAT 
CGGCAAACCGAAAGCGGTACGGGCCGTTGCAAGTGCCTGTGCCGCCAACC 
CTGTCCCCATCCTC-3'), 5-reg2 (5'-TGGCAGGCACTGCGCACGATACCTTG 
CGGTGAAACCGTCAGTTATCAGCAACTGGCAGCCCTGGCAGGC-3'), 5-reg3 (5'-
CCGCTGGACATTCGCGGCACTGCTTTTCAGCAAGAGTCGTTCACCAGACAG-3'), 5-
reg4 (5'-GAAGTGATCGCCAGCCTCAATCAACGCGATACGCCGCTGTTCCC 
CGTGCCGGCTCTT-3'), 5-reg5 (5'TTGCTGGGCGATGATGACGCCACA 
TTAGATGCCGTGGAGGTC-3), or pr2 (described above). Primers 3-
regl, 3-reg2, 3-reg3, 3-reg4, and 3-regS contain at their 5' 
ends ada nt complementary to 5-regl, 5-reg2, 5-reg3, 5-reg4, 
and 5-reg5 primers, respectively. The conditions for the PCR 
amplification reaction were as described above. Following 
amplification, 80µ1 of each PCR reaction mixture were 
fractionated by electrophoresis ( 100v, 1hr) along with a 
molecular weight marker in a 1% agarose gel to confirm the 
size of the amplification products. Each PCR-amplified DNA 
fragment was excised from the agarose gel and 
purified (Geneclean II, Biol0l Inc., LaJolla, CA.) . PCR-
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generated, purified cDNA fragments (lµg) were then used in a 
subsequent PCR overlap extension reaction. Aliquots from. two 
separate PCR reactions containing the overlapping fragments 
were mixed and subjected to a second PCR amplification using 
a pair of external synthetic oligonucleotides prl and adadn 
(amplified MGMT-ada cDNAs) , adaup and pr2 (amplified ada-MGMT 
cDNAs), or prl and pr2 (amplified MGMT-ada-MGMT cDNAs). The 
reaction conditions used for the fusion of the two PCR-
generated cDNA fragments were identical to those described 
above. Following amplification the size of the products were 
confirmed by agarose gel electrophoresis. Two sets of 
primers, prl-chim3 and adadn-chim4 were used to construct a 
553-bp cDNA fragment which encodes an MGMT-PCHRV-ADA chimera 
fused at the PCHRV acceptor site. Primers prl-3glhe and 
adadn-Sglhe were used to construct a 550-bp cDNA fragment 
which encodes a protein fused at the MGMT glycine-leucine-
histidine-glutamic acid (GLHE) sequence (MGMT-GLHE-ADA). 
Primers adaup-chiml and pr2-chim2 were used to construct a 
630-bp cDNA fragment which encodes an ADA-PCHRV-MGMT chimera 
fused at the PCHRV acceptor site. Primers adaup-3lelsg and 
pr2-5lelsg were used to construct a 640-bp cDNA fragment 
which encodes a protein fused at the MGMT leucine-glutamic 
acid-leucine-serine (LELS) sequence (ADA-LELS-MGMT). Primers 
adaup-tailada and pr2-tailmgmt were used to construct a 637-
bp cDNA fragment which encodes an Ada protein (ADA-MGMTTAIL) 
fused to the MGMT carboxyl-terminal tail. Primers prl-3regl 
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and 5regl-pr2 were used to construct a 645-bp cDNA fragment 
which encodes a chimeric protein containing Ada aa 118~137 
(MGMT-ADAl-MGMT). Primers prl-3reg2 and 5reg2-pr2 were used 
to construct a 645-bp cDNA fragment which encodes a chimeric 
protein containing Ada aa 99-117 (MGMT-ADA2-MGMT). Primers 
prl-3reg3 and 5reg3-pr2 were used to construct a 642-bp cDNA 
fragment which encodes a chimeric protein containing Ada aa 
79-92 (MGMT-ADA3-MGMT). Primers prl-3reg4 and 5-reg4-pr2 
were used to construct a 645-bp cDNA fragment which encodes 
a chimeric protein containing Ada aa 66-78 (MGMT-ADA4-MGMT). 
Primers prl-3reg5 and 5reg5-pr2 were used to construct a 642-
bp cDNA fragment which encodes a chimeric protein containing 
Ada aa 32-41 (MGMT-ADAS-MGMT). 
In addition to the generation of the full-length, 
truncated and chimeric MGMT and ada cDNAs, four synthetic, 
MGMT acceptor site-containing oligopeptides (Peptide 1= 
PCHRV, Peptide 2= GNPVPILIPCHRVVCSSGAV, Peptide 3= 
AMRGNPVPILIPCHRV, and Peptide 4= PCHRVVCSSGAVGNYS) (Tano et 
al., 1990) were commercially synthesized and HPLC purified 
(Chiron Mimotopes) . The oligopeptides were approximately 68-
75% pure. 
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n. Preparation of Competent Alkyltransferase Deficient E. 
coli Cells 
A single colony of E. coli ada-ogt- cells was aseptically 
inoculated into 50 ml LB media containing ampicillin 
(l00µg/ml) and the bacterial culture was grown overnight at 
37°c in a shaking incubator (250 rpm). The overnight culture 
was diluted (1:100 in LB broth) and grown as described above 
to an O. D. 590 of 0. 3 to 0. 4. The bacterial culture was 
aliquoted into prechilled, sterile polypropylene tubes and 
cooled on ice for 10 min. The bacterial cells were pelleted 
(1,600 g, 7 min, 4°C), resuspended in 10 ml ice-cold CaC1 2 
solution (60mM CaC1 2 , 15% glycerol, l0mM PIPES, pH 7.0), and 
repelleted (1,100 g, 5 min, 4° C). The bacterial cells were 
resuspended in 10 ml ice-cold CaC1 2 solution and left on ice 
for 30 min. The competent bacterial cells were pelleted 
(1,100 g, 5 min, 4°C), resuspended in 2 ml of ice-cold CaC1 2 
solution, aliquoted into prechilled microcentrifuge tubes, 
and stored at -so 0c. 
E. Subcloning of MGMT and ada cDNAs into a Bacterial 
Expression Vector 
Ten µg of PCR products and the 4.9kb pGEX-3X bacterial 
expression vector (50 µg; Pharmacia LKB) were digested 
sequentially with BamHl and EcoRl (5U/µg, 37°C, 2 h). 
Between digests, the DNA was extracted (once with an equal 
volume phenol /24:1 chloroform-isoamyl alcohol, and once with 
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an equal volume 24:1 chloroform-isoamyl alcohol), ethanol 
precipitated (0.1 vol 3M sodium acetate, 2 vol ethanol, l_h,-
so0C) and pelleted (12,000 g, 30 min, 4°C). The DNA pellet 
was dried under vacuum and resuspended in a buffer containing 
1omM Tris-HCl and lmM EDTA, pH 8.0. Digestion products were 
fractionated by electrophoresis in a 1.0% agarose gel at 20 
v for 16 h. The PCR products were excised from the agarose 
gel, purified (Geneclean II, BIO 101 Inc.) and ligated (14°C, 
16 h, lU T4 DNA ligase) separately into a BamHl-EcoRl 
digested pGEX-3X plasmid (3:1 molar ratio of insert:vector 
DNA). The ligation reaction was diluted 1:5 in deionized H20 
and used to transform competent E. coli ada-ogt-cells. 
Transformed ada-ogt- cells were plated onto LB agar plates 
containing 100 µg/ml ampicillin and were incubated at 37°C 
for 16 h. Bacterial colonies were randomly chosen from each 
plate, grown in culture (100 ml LB broth, l00µg/ml 
ampicillin) and used for plasmid DNA isolation (Wizard 
Minipreps DNA purification system; Promega, Madison, WI.). 
The identity of the subcloned DNA was confirmed by plasmid 
DNA (lµg) digestion with BamHl and EcoRl (l0U/µg, 37°C, 2 h). 
DNA sequencing (Taq Track, Promega, Inc., Madison, WI.) was 
performed to verify the 5' and 3' MGMT mutations, the absence 
of any PCR-induced point mutations within the MGMT cDNA 
encoding MGMT-C28, and the junction sites of all the MGMT-
ada, ada-MGMT, and MGMT-ada-MGMT chimeric cDNAs. 
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F. Isolation of GST-MGMT, GST-Ada, and GST-Chimeric Fusion 
Proteins from E. coli 
To express the full-length and truncated GST-MGMT, GST-
Ada, or GST-chimeric fusion proteins, E. coli ada-ogt-
colonies transformed with recombinant pGEX-3X plasmids, were 
grown overnight (10 ml LB broth, l00µg/ml ampicillin) and 
then diluted (inoculated 3ml of the culture into 30 ml LB 
media) and incubated at 37°C for 1 h in a shaking incubator. 
Fusion protein expression was induced by incubation of 
bacterial cultures with 0. lmM IPTG (25°C, 90 min) . The 
bacterial cells were pelleted (3,000g, 10 min, 22°C), 
resuspended in 600 µl alkyltransferase buffer ( 0. 05M Tris-HCl 
pH 8.0, 0.lmM EDTA, 5mM dithiothreitol, 5% glycerol), lysed 
on ice by mild sonication (3X-5 s bursts; 30 s pause between 
bursts) and repelleted (10,000g, 15 min, 4°C). The 
supernatant and pellet fractions, from induced and non-
induced bacterial cultures (100 µg), were added to lX SDS-
reducing buffer (2X buffer= 0 .125 M Tris-HCl pH 6. 8, 20% 
glycerol, 2% SDS, 2% B-mercaptoethanol, 0.001% bromophenol 
blue) and heated at 95°C for 5 min. The debris from the 
pellet and supernatant fractions was pelleted by 
centrifugation at 10,000 g for 2 min. The supernatants from 
each fraction were analyzed for size on a 12.5% 
polyacrylamide-SDS gel using a lX SDS-PAGE running buffer 
(20mM Tris-Base, 200mM glycine, 0.1% SDS, 5 h, 20 milliamps), 
along with a SDS-PAGE low molecular weight marker (BIO-RAD, 
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Bio-Rad Laboratories, Richmond, CA.) followed by Coomassie 
blue staining ( 0. 05%) (described below) . Bacter;ial 
supernatant fractions containing soluble GST-chimeric, GST-
MGMT or GST-Ada fusion proteins were either directly assessed 
for repair of O6 -MG in DNA or served as the starting material 
from which fusion or cleaved fusion proteins were isolated. 
For further purification, the bacterial supernatant (500 µg-
1. o mg total protein) containing fusion proteins was added to 
a glutathione Sepharose affinity column (equilibrated with 10 
bed vol lX PBS: 150mM NaCl, 16mM Na2HPO4 , 4mM NaH2 PO4 , pH 7.3, 
1% Triton X-100; Pharmacia LKB) and the eluent was discarded. 
The column was washed (3X-10 bed vol lX PBS) and the 
glutathione-bound fusion protein was either eluted from the 
column with 2 ml glutathione buffer (5mM glutathione in 50mM 
Tris-HCl, pH 8.0) or cleaved from the column by addition of 
Factor Xa (1:100 enzyme:substrate molar ratio, 25°C, 3 h; 
Pierce, Rockford, Il) in a 500µ1 buffer containing 1% BSA, 
5mM MES, O. 5M NaCl, pH 6. O. The fusion and hydrolyzed 
proteins (20µg) were fractionated by electrophoresis on a 
polyacrylamide-SDS gel along with a low molecular weight 
marker (BIO-RAD) followed by Coomassie blue (0.05%) or silver 
staining. 
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G. Staining of SDS-Polyacrylamide Gels 
All full-length, mutant and chimeric MGMT and Ada fusion 
and hydrolyzed proteins, after separation on 12. 5% 
polyacrylamide-SDS gels, were either Coomassie blue or silver 
stained. For Coomassie blue staining, the SDS-PAGE gels 
containing the GST-MGMT, GST-Ada, and GST-chimeric fusion 
proteins were soaked in 45% methanol, 10% acetic acid, 0.1% 
Coomassie blue R-250 (200 ml total volume) for 30 min on a 
rotator at 25°C. To destain, the gels were rinsed with 
several washes (3X- 30 min for each wash) of 20% methanol, 
10% acetic acid. Prior to drying (described below), gels 
were soaked in 20% methanol, 3% glycerol overnight at 25°C. 
For silver staining, the SDS-PAGE gels containing the 
factor-Xa cleaved control and mutant MGMT and Ada proteins 
were soaked in a 500 ml solution containing 10% acetic acid, 
5% sulfosalicylic acid, 40% ethanol for 4 hon a rotator at 
25°C. The gels were rinsed with 20% ethanol (4x- 20 min for 
each wash), and soaked in a 500 ml silver nitrate solution 
for 90 min. The silver nitrate solution was prepared by 
adding 25 ml 10% silver nitrate dropwise to a solution (475 
ml) containing 20% ethanol, 0.15% NaOH, 1.0% NH4 OH, with 
constant stirring. The gels were washed with 20% ethanol 
(3X- 20 min for each wash) and soaked in a developing 
solution (prepared by mixing 0.5 ml 10% citric acid with 0.75 
ml 37% formaldehyde in 500 ml dH2O) for 15 min or until the 
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silver-stained protein bands appeared. The reaction was 
stopped by rinsing the gels in 1% acetic acid. The gels were 
washed in dH20 (3X- 20 min for each wash), wrapped in gel 
drying paper (Pharmacia, LKB) and dried under vacuum. 
H. Protein Quantitation 
Total protein content of bacterial sonicates containing 
fusion proteins, purified fusion proteins, and purified 
cleaved fusion protein preparations was determined by a 
Bradford protein assay program (Bio-rad assay; Bio-Rad Lab.) 
using as a standard bovine serum albumin (1-l0µg) (Bradford, 
1976) . 
Concentrations of non-purified control, truncated and 
chimeric MGMT and Ada fusion proteins were estimated as 
follows: non-purified fusion proteins (S0µg total protein) 
were fractionated by electrophoresis on a 12.5% 
polyacrylamide-SDS gel and stained with Coomassie blue. The 
relative amount (µg) of each fusion protein was assessed by 
comparing the intensity of the Coomassie blue stained fusion 
protein band to that of the sum of all other protein bands. 
Concentrations of purified control, truncated and 
chimeric MGMT and Ada fusion proteins (MGMT, MGMT-C28, MGMT-
PCHRV-ADA, ADA, ADA-PCHRV-MGMT, and ADA-MGMTTAIL) were 
determined in two independent experiments. First, these 
purified fusion proteins (20 µg) were fractionated by 
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electrophoresis on a 12.5% polyacrylamide-SDS gel and stained 
with 0.05% Coomassie blue. The amount of each fusion pro~ein 
was calculated by densitometric scanning (Tri Microscan 
system, Technology Res., Inc., Nashville, TN). The MGMT and 
Ada fusion protein content was assessed by comparing the 
optical density of the fusion protein band to that of a 
similarly fractionated bovine serum albumin protein band (l-
25µg). Second, equivalent amounts (1.6 pmol) of MGMT, MGMT-
C28, MGMT-PCHRV-ADA, ADA, ADA-PCHRV-MGMT, and ADA-MGMTTAIL, 
as calculated by densitometric analysis, were assessed in 
triplicate for the ability to completely repair varying 
amounts of an 0 6 -MG containing DNA substrate (1.0-2.2 pmol 
DNA substrate, 2 h, 37°C, as described below). Due to the 
stoichiometric nature of the repair reaction, the highest DNA 
concentration at which repair is complete is equal to the 
alkyltransferase concentration in the protein extract. 
I. Preparation and Labeling of an 18 bp 0 6 -MG-Containinq 
DNA Substrate 
The synthetic 18-bp 0 6 -MG-containing 
oligodeoxynucleotide substrate was prepared by the 
hybridization of two complementary 18-mer and 16-mer 
oligodeoxynucleotide strands (Wu et al., 1987). The 18-mer 
(440 pmol) and 16-mer (400 pmol) were added to a 100 µl 
buffer (lmM EDTA, l0mM Tris-HCl pH 8.0, 33mM NaCl), denatured 
at 90°C for 10 min, and then quickly placed in a 70°C water 
40 
bath overnight (H20 bath was immediately turned off to allow 
for hybridization) . Following hybridization of . the 
complementary strands, the 18-bp oligomer (4 pmol/µl), which 
contains two unpaired bases at one end, served as template 
for the Stoffel fragment of Taq DNA polymerase (fills in the 
23' recessed end with thymidine 5'-[a- 32 P] -triphosphate; 
Amersham, Arlington Heights, Il) (Figure 3). Twenty pmol of 
the 18-bp DNA substrate were incubated with 10 U2 Stoffel Taq 
DNA polymerase (Perkin Elmer/Cetus), S0µCi of [a- 32 P] dTTP 
(specific activity 3000 Ci/mmol), 1.SmM MgC1 2 , and lX Stoffel 
Taq buffer (Perkin Elmer/Cetus) at 42°C for 1 h in a total 
volume of 20µ1. Following DNA labeling, the 18-bp oligomer 
from this reaction was extracted (once with an equal volume 
phenol/24: 1 chloroform-isoamyl alcohol, and once with an 
equal volume 24:1 chloroform-isoamyl alcohol), ethanol 
precipitated (0.1 vol 3M sodium acetate, 20µg tRNA, 2 vol 
ethanol, 1 h, -80°C), pelleted (12,000 g, 30 min) and dried 
under vacuum. The 32P-end-labeled 18-bp oligodeoxynucleotide 
substrate was resuspended in 100µ1 dH20 (final concentration 
assumed to be 0.2 pmol/µ1) and stored at 4°C. 
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HaeIII) 
I me 
5, -GCCCGGCC~A~~T_G __CAGTT-32P 
PvuII 
CGGGCCGGT ACGTCAA 
(lObp) (8bp) 
Figure 3. Specific sequence of the oligodeoxynucleotide 
probe. The 32 P-end-labeled 18 bp oligonucleotide substrate 
contains a single methyl lesion at the 0 6 -position of guanine 
within a PvuII restriction site. Vertical lines, position of 
cleavage of the restriction enzymes HaeIII or PvuII. 
Horizontal line, defines the PvuII restriction site (Wu et 
al., 1987). 
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J. Assay for Repair of 0 6 -MG in DNA 
Repair of 0 6 -MG containing DNA by four MGMT 
oligopeptides and bacterial sonicates containing control, 
truncated or chimeric MGMT and Ada fusion proteins was 
assessed in triplicate by a restriction endonuclease 
inhibition assay (Wu et al., 1987; Futscher et al., 1989). 
MGMT oligopeptides 1-4 (25 µg) and ada-ogt- cell extracts 
containing the control or mutant Ada or MGMT fusion proteins 
(0-200 µg) were reacted separately with 0.2 pmol of a 32 P-end 
labeled 18 bp 0 6 -MG containing DNA substrate at 37°C for 2 h 
in 150µ1 alkyltransferase buffer. As described, the 18-bp 
oligonucleotide substrate contains a single methyl lesion at 
the O6 -position of guanine within a PvuII site (Figure 3) (Wu 
et al., 1987). After incubation, the DNA from this reaction 
was extracted, ethanol precipitated, pelleted (12,000xg, 30 
min) and dried under vacuum. The DNA was resuspended in 17µ1 
dH20 and 2µ1 l0X react 6 buffer (BRL) and then incubated with 
PvuII (l0U, 37°C, 1 h). Three unreacted control samples were 
incubated with either no restriction endonuclease, PvuII, or 
HaeIII (l0U, 37°C, 1 h). All digestion reactions were 
terminated by addition of 9µ1 of 95% formamide dye (95% 
formamide, lmM EDTA, 0.1% Bromophenol blue, 0.1% Xylene 
Cyanol). Following denaturation at 95°C, the DNA sample was 
quickly cooled on ice and fractionated by electrophoresis ( 10 
µl aliquots) on a 20% denaturing polyacrylamide gel (26 
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milliamps, 1 h). The amount of restriction enzyme-cleaved 
DNA substrate was visualized through direct _gel 
autoradiography (18 h, -80°C), quantitated by analysis on a 
Betascope 630 (Betagen, Inc.), and compared to the amount of 
DNA uncleaved in each sample. Repair activity was expressed 
as percent PvuII-mediated cleavage of the protein-reacted DNA 
relative to HaeIII-mediated cleavage of the same DNA 
substrate. 
The rate of repair of the 18-bp 0 6 -MG-containing DNA 
substrate by MGMT, MGMT-C28, and Ada purified fusion proteins 
was measured in triplicate at 4°C and 37°c using the 
restriction endonuclease inhibition assay as described above. 
For analysis at 4°C, the 32P-end-labeled 18-bp DNA substrate 
(0.2 pmol) was incubated for various times (0-400 min) with 
Ada and MGMT purified fusion proteins (1.6 pmol) in a 150µ1 
total reaction volume. For analysis at 37°c, purified MGMT 
fusion proteins (1.6 pmol) were reacted with the DNA 
substrate (0.02 pmol) for 0-30 min in a 300µ1 total reaction 
volume. 
K. Analysis of 0 6 -BG Repair Activity 
The ability of MGMT oligopeptides and bacterial 
sonicates containing MGMT control and truncated fusion 
proteins to repair 8-[ 3H]-06 -benzylguanine was determined in 
triplicate by incubating 11.5 pmol of 8-[ 3H]-06 -benzylguanine 
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with an estimated 100-fold molar excess of Peptides 1-4, 
MGMT-C35, MGMT-N18, MGMT-N78, MGMT, or Ada fusion proteins in 
20µ1 alkyltransferase buffer for 2 h at 37°C. 8- [3H] -O6 -
benzylguanine was prepared by Amersham Corporation and was 
purified by M.E. Dolan (1991). A control incubation without 
added protein was carried out for the same time in the same 
buffer. After incubation, the reactions were terminated by 
addition of 500µ1 of the reaction buffer containing unlabeled 
200µM guanine (Sigma, St. Louis, MO) and 200µM benzylguanine 
(provided by R.C. Moschel). Measurements of 8-[ 3H]guanine 
formation from 8-[3H]-O6 -benzylguanine for each sample were 
determined by reverse phase HPLC separation (Rainin 
Lichrosorb RP18 column) of the compounds. The samples (520 
µ1) were eluted with 50% methanol/0.05M ammonium formate pH 
4.5 at 35°C with a flow rate of 1 mL/min. Authentic guanine 
(retention time= 4 min) and O6 -benzylguanine (retention time= 
10 min) were detected using a Waters UV detector at a 
wavelength of 280 nm. Radioactivity corresponding to these 
peaks was monitored by use of a radioactivity flow detector 
(Radiomatic, Inc., Tampa, Fl.). 
The rate of O6 -BG repair by full-length, truncated, and 
chimeric MGMT and Ada fusion proteins was measured in 
triplicate by incubating O6 -BG (16 pmol) 
MGMT-C28, ADA-PCHRV-MGMT, MGMT-PCHRV-ADA, 
with Ada, MGMT, 
and ADA-MGMTTAIL 
(1.6 pmol) purified fusion proteins and ADA-LELS-MGMT, MGMT-
GLHE-ADA, MGMT-ADAl - MGMT, MGMT-ADA2 - MGMT, MGMT-ADA3 - MGMT, and 
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MGMT-ADA5-MGMT (50µg) non-purified fusion proteins in 300µ1 
alkyltransferase buffer for 0-30 min at 37°C. Following 0 6 ~BG 
pre-exposure, 0.02 pmol of 32P-end labeled 0 6 -MG containing 
DNA were added, in the presence of 0 6 -BG, and the reaction 
was further incubated for 2 h at 37°C. BG-mediated 
inhibition of 0 6 -MG repair was indirectly monitored by the 
restriction endonuclease inhibition assay (described above). 
0 6 -BG-mediated inactivation was expressed as percent 
inhibition of PvuII-mediated cleavage of the protein-reacted 
DNA relative to non-PvuII digested DNA. 
L. Assay for Repair of 0 4 -MT in DNA 
The ability of MGMT, Ada, and chimeric fusion proteins 
to repair 0 4 -methyl[ 3H]thymine in poly(dA)-poly(dT) was 
determined in triplicate by incubating N-[ 3H]methyl-N-
nitrosourea-exposed poly(dA) -poly(dT) substrate 
(approximately 0.5 pmol 0 4 -methyl[3H]thymine) with a 100-fold 
molar excess of purified MGMT, Ada, MGMT-PCHRV-ADA, or ADA-
PCHRV-MGMT fusion proteins in 50µ1 alkyltransferase buffer 
for 2 hat 37°C. A control incubation without added protein 
was carried out for the same time in the same buffer. 
[ 3H] methylated poly (dT) /poly (dA) substrate was prepared by 
the reaction of 25 units poly (dT) with O. lmCi N- [3H] methyl-N-
nitrosourea (Amersham Corp.) in 100µ1 0.05M Tris, pH 8.0 at 
37°C for 1 h. The alkylated poly(dT) was extracted (once 
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with an equal volume of phenol/24:1 chloroform-isoamyl 
alcohol, and once with an equal volume 24: 1 chloroform-
isoamyl alcohol), ethanol precipitated (0.1 vol 3M sodium 
acetate, 2 vol ethanol, 1 h, -80°C), pelleted (16,000g, 30 
min, 4°C) and dried under vacuum. The poly(dT) pellet was 
resuspended in 0.05M Tris, pH 8.0 and annealed to 25 units 
poly(d.A) in 500µ1 of the same buffer at 25°C for 2 h. Each 
sample described above was cooled to o0c and incubated with 
deoxyribonuclease I (660u/mL) (Sigma) in 500µ1 0. 0lM magnesium 
acetate pH 6. 5 buffer for 1 h at 3 7°C. E. coli alkaline 
phosphatase (8u/mL) (Sigma) and snake venom phosphodiesterase 
(0.2u/mL) (Pharmacia, LKB) were subsequently added (pH of the 
magnesium acetate buffer was adjusted to 8.0) for 18 hat 
37°C. Proteins were precipitated (95°C, 10 min) and pelleted 
(16,000g, 1 h), and the remaining supernatant was analyzed 
for 0 4 -methylthymine, 3-methylthymine, and 0 2 -methylthymine 
by reverse phase HPLC separation (Rainin Lichrosorb RP18 
column) of the compounds. The samples (250 µl total volume) 
were eluted with 20% methanol/0.05M ammonium formate pH 4.5 
at 35°c with a flow rate of lmL/min and the columns were 
washed with 100% methanol for 30 min. 0 4 -methylthymine 
(retention time= 18 min), 3-methylthymine (retention time= 12 
min), and 0 2 -methylthymine (retention time= 7.5 min) (Chemsyn 
Science Lab., Lenexa, KS) were detected using a Waters UV 
detector at a wavelength of 254nm. Radioactivity from sample 
fractions (1 fraction/min collected) corresponding to these 
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peaks was monitored through use of a scintillation counter. 
Q4 -MT repair was determined by comparing 0 4 -methyl[ 3H] thymine 
content in poly(dA)-poly(dT) exposed to full-length or 
chimeric MGMT and Ada proteins to that in control poly(dA)-
poly(dT) substrate. 
CHAPTER IV 
RESULTS 
A. Construction of Full-Length, Truncated, and Chimeric MGMT 
and Ada Fusion Proteins 
1. Construction of GST-MGMT. GST-Ada, and GST-chimeric 
bacterial expression vectors 
All full-length and truncated human MGMT and E.coli ada 
cDNAs were synthesized by PCR and all MGMT-ada, ada-MGMT, and 
MGMT-ada-MGMT chimeric cDNAs were generated using the PCR 
overlap extension technique (Ho et al., 1989). These products 
were generated using conditions (high template concentration, 
low cycle number) demonstrated to minimize Taq polymerase-
induced mutation (Ho et al., 1989). All products were of the 
predicted size as assessed by agarose gel electrophoresis 
next to molecular weight markers (representative examples are 
shown in figure 4) (Demple et al., 1985; Tano et al., 1990). 
Each gel-purified, PCR-generated cDNA, after sequential EcoRl 
and BamHl digestion, was subcloned into the pGEX-3X bacterial 
expression vector which in turn directs the synthesis of 
glutathione S-transferase (GST)-MGMT, GST-ADA, and GST-
chimeric fusion proteins in E.coli under the control of the 
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Figure 4. PCR amplification of control and mutant MGMT and 
ada cDNAs . MGMT (645 bp), ADA-PCHRV-MGMT (630 bp), ADA (553 
bp), MGMT-PCHRV-ADA (553 bp), AND MGMT-C28 (549 bp) cDNAs 
(Lanes 1-5, respectively) were synthesized by PCR and 
subsequently analyzed by electrophoresis on an ethidium 
bromide-containing 1.0% agarose gel and photographed. Sizes 
of a 123-bp ladder are also indicated. 
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IPTG-inducible tac promoter. Sequencing (approximately 50-70 
nt) across the fusion sites of all MGMT-ada and ada-MGMT 
chimeric cDNAs, and the junction of either the 3' or 5' end 
of the MGMT cDNAs and the bacterial expression vector, 
confirmed that in each case the desired cDNA fusion or 
deletion was accomplished. Sequencing of the fusion sites of 
the five MGMT-ada-MGMT chimeric cDNAs confirmed that the 
desired ada nt substitutions were accomplished. One 
exception, however, was the MGMT-ada4-MGMT construct which, 
for those cDNAs analyzed, was found to be the wildtype MGMT 
cDNA sequence. All subsequent studies, therefore, excluded 
the analysis of MGMT-ADA4-MGMT. 
2. Expression and isolation of GST-MGMT, GST-Ada, and 
GST-chimeric fusion proteins 
To produce soluble full-length, truncated, or chimeric 
MGMT and Ada fusion proteins, ada-ogt- cells transformed with 
recombinant pGEX-MGMT, pGEX-ada, or pGEX-chimeric cDNA 
constructs were incubated with IPTG at room temperature for 
90 min. Supernatant and pellet fractions (l00µg) derived from 
ada-ogt- whole cell sonicates containing these fusion proteins 
were analyzed on a series of polyacrylamide-SDS gels to 
demonstrate that all proteins were stable, and of the 
predicted size encoded by the expression vectors. Diagrams 
of full-length, truncated, and chimeric MGMT and Ada fusion 
proteins, in addition to the MGMT oligopeptides, are shown in 
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Figure 5. Diagrams of the full-length, truncated, and 
chimeric MGMT and Ada fusion proteins and MGMT oligopeptides. 
All full-length, truncated, or chimeric MGMT (hatched box) 
and Ada (open box) constructs were expressed as GST-fusion 
proteins. The thick and thin black boxes indicate the MGMT 
28 aa carboxyl-terminal tail and the PCHRV acceptor site, 
respectively. The names of each truncated MGMT protein 
designate the aa deletion made at either the amino- or 
carboxyl-terminus. The names of MGMT/Ada and Ada/MGMT 
chimeric proteins indicate the aa sequences joining the two 
proteins. The MGMT-ADA-MGMT chimeric proteins each contain 
approximately 10-20 Ada aa in place of MGMT aa. The small 
Ada aa substitutions for the MGMT-ADA-MGMT proteins span from 
the MGMT amino-terminal GLHE region to the PCHRV acceptor 
site. All MGMT oligopeptides contain the conserved PCHRV 
acceptor site. 
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Figure 5. Figure 6 represents an SDS-PAGE analysis of 
supernatant fractions derived from ada-ogt- whole cell 
sonicates containing either MGMT (48 kDa), MGMT-C65 (41 kDa, 
faint in this preparation), MGMT-ClO (47 kDa), MGMT-C28 (45 
kDa), or Ada (45 kDa) (lanes 3-7, respectively) . Arrows 
indicate the fusion protein of the predicted size encoded by 
the expression vectors. These proteins were expressed only 
in bacteria pre-exposed to IPTG and were not present in non-
transformed bacteria (Figure 6, lane 2) or in HT-29 cell 
sonicates (Figure 6, lane 1). Figure 7 represents a similar 
SDS-PAGE analysis of pellet and supernatant fractions derived 
from IPTG-induced bacterial cultures containing either MGMT-
C35 (44 kDa) (lanes 5, 6), MGMT-N18 (46 kDa) (lanes 9, 10), or 
MGMT-N78 (39 kDa, faint in this preparation) (lanes 13, 14). 
All fusion proteins, as indicated by the arrows, were of the 
predicted size and all soluble proteins were readily 
detectable in supernatant fractions. These proteins, 
however, were not present in supernatant and pellet fractions 
from either non-transformed, sonicated ada-ogt- cells (Figure 
7, lanes 1, 2) or from non- IPTG induced bacterial cells 
transformed with MGMT cDNA constructs encoding either MGMT-
C35 (lanes 3,4), MGMT-N18 (lanes 7,8), or MGMT-N78 (lanes 
11,12). SDS-PAGE analysis of supernatant and pellet 
fractions derived from ada-ogt- whole cell sonicates 
containing either ADA-PCHRV-MGMT (48 kDa) (Figure 8, lanes 
1,2), MGMT-PCHRV-ADA (45 kDa) (lanes 3,4), ADA-MGMTTAIL (48 
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Figure 6 . SDS-PAGE analysis of ada-ogt- whole cell sonicates 
containing either GST-MGMT or GST-Ada fusion proteins. 
Alkyltransferase deficient whole cell sonicates (100 µg total 
protein/lane) containing IPTG-induced MGMT(48kDa), MGMT-C65 
(41kDa), MGMT-Cl0 (47kDa), MGMT-C28 (45 kDa), or Ada (45kDa) 
fusion proteins (Lanes 3-7, respectively) were fractionated 
by electrophoresis through a 12. 5% polyacrylamide-SDS gel 
followed by Coomassie blue staining (0.05%). Arrows indicate 
the fusion protein of the predicted size. Positions and sizes 
of a Bio-Rad SDS-PAGE low molecular weight standar d are 
indicated. These fusion proteins were not present in HT-29 
colon carcinoma cell sonicates (lane 1) or in non-transformed 
ada-ogt- cell sonicates (lane 2). 
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Figure 7. SDS-PAGE analysis of ada-ogt- whole cell sonicates 
containing either MGMT-C35, MGMT-N18, or MGMT-N78 fusion 
proteins. Pellet (P) and supernatant (S) fractions (lOOµg 
total protein/lane) derived from IPTG-induced bacterial 
cultures containing either MGMT-C35 (44 kDa) (lanes 5, 6), 
MGMT-N18 (46 kDa) (lanes 9, 10), or MGMT-N78 (39 kDa) (lanes 
13, 14) fusion proteins were fractionated by electrophoresis 
through a 12.5% polyacrylamide SDS-gel followed by Coomassie 
blue staining (0.05%) Arrows indicate the fusion protein of 
the predicted size. These fusion proteins were not present 
in supernatant and pellet fractions from either non-
transformed, sonicated ada-ogt- cells (lanes 1, 2) or from 
non-IPTG induced bacterial cells transformed with MGMT cDNA 
constructs encoding either MGMT-C35 (lanes 3, 4), MGMT-N18 
(lanes 7, 8), or MGMT-N78 (lanes 11, 12). 
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Figure 8. SDS-PAGE analysis of ada-ogt- whole cell sonicates 
containing either ADA-PCHRV-MGMT, MGMT-PCHRV-ADA, or ADA-
MGMTTAIL fusion proteins. Supernatant (s) and pellet (p) 
fractions (lOOµg total protein/lane) derived from IPTG-
induced bacterial cultures containing either ADA-PCHRV- MGMT 
(48 kDa) (lanes 1 , 2), MGMT-PCHRV-ADA (45 kDa) (lanes 3, 4), or 
ADA-MGMTTAIL (48 kDa) (lanes 5, 6) fusion proteins were 
fractionated by electrophoresis through a 12.5% 
polyacrylamide SDS-gel followed by Coomassie blue staining 
(0.05%). Arrows indicate the fusion protein of the predicted 
size. These fusion proteins were not present 1.n non-
transformed ada-ogt- cell sonicates (lane 7). 
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48 kDa) (lanes 5,6), MGMT-ADAl-MGMT (48 kDa) (Figure 9, lanes 
2,3), MGMT-ADA2-MGMT (48 kDa) (lanes 4,5), MGMT-ADA3-MGMT (48 
kDa) (lanes 
LELS-MGMT 
6,7), MGMT-ADAS-MGMT (48 kDa) (lanes 8,9), ADA-
(48 kDa) (lanes 10, 11), or MGMT-GLHE-ADA (45 
kDa) (lanes 12,13) yielded similar results (i.e. all fusion 
proteins were soluble and of the predicted, and were not 
present in nontransformed bacteria) (Figure 8, lane 7; Figure 
9, lane 1) . 
Bacterial supernatant fractions containing soluble GST-
chimeric, GST-MGMT, or GST-Ada fusion proteins were either 
directly assessed for repair of 0 6 -MG-containing DNA 
(described below) , or were further purified by affinity 
chromatography on immobilized glutathione. The purified 
fusion and factor Xa-cleaved fusion proteins were analyzed 
for size and purity on a polyacrylamide-SDS gel followed by 
Coomassie blue or silver staining. SDS-PAGE analysis of 
purified MGMT, ADA-MGMTTAIL, Ada, MGMT-C28 (Figure 10, lanes 
1-4, respectively), ADA-PCHRV-MGMT, MGMT-PCHRV-ADA (Figure 
11, lanes 1, 2, respectively) , MGMT-ADAl-MGMT, MGMT-ADA2-MGMT, 
MGMT-ADA3-MGMT, and MGMT-ADAS-MGMT (Figure 12, lanes 1-4, 
respectively) GST-fusion proteins (20 µg) demonstrated that 
these proteins were the predominant peptide in each 
preparation. These GST-fusion proteins represented, by 
densitometric scan of the gel, approximately 80% of the total 
protein. This represents a greater than 10-fold purification 
relative to the non-fractionated sonicates containing the 
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Figure 9. SDS-PAGE analysis of ada-ogt- whole cell sonicates 
containing MGMT and Ada chimeric fusion proteins. 
Supernatant (s) and pellet (p) fractions (lOOµg total 
protein/lane) derived from IPTG-induced bacterial cultures 
containing either MGMT-ADAl-MGMT (48 kDa) (lanes 2 , 3), MGMT-
ADA2-MGMT (48 kDa) (lanes 4, 5), MGMT-ADA3-MGMT (48 kDa) (lanes 
6, 7), MGMT-ADAS-MGMT (48 kDa) (lanes 8, 9), ADA-LELS-MGMT (48 
kDa) (lanes 10, 11), or MGMT-GLHE-ADA (45 kDa) (lanes 12, 13) 
fusion proteins were fractionated by electrophoresis through 
a 12.5% polyacrylamide SDS-gel followed by Coomassie blue 
staining (0.05%). Arrows indicate the fusion protein of the 
predicted size. Positions and sizes of a Bio-Rad SDS-PAGE 
low molecular weight standard are also indicated. These 
fusion proteins were not present in non-transformed ada-ogt-
cell sonicates (lane 1). 
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Figure 10. SDS-PAGE analysis of GST-affinity purified MGMT 
and Ada GST-fusion proteins. Purified MGMT (48 kDa) , ADA-
MGMTTAIL (48 kDa), ADA (45 kDa), and MGMT-C28 (45 kDa) (lanes 
1-4, respectively) GST-fusion proteins (20µg/lane) were 
fractionated by electrophoresis through a 12.5% 
polyacrylamide SDS-gel followed by Coomassie blue staining 
(0.05%) . Arrows indicate the purified fusion protein of the 
predicted size (positions and sizes of a Bio-Rad SDS-PAGE low 
molecular weight standard are also indicated). 
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Figure 11. SDS-PAGE analysis of GST-affinity purified ADA-
PCHRV-MGMT and MGMT-PCHRV-ADA GST-fusion proteins . Purified 
ADA-PCHRV-MGMT (48 kDa) and MGMT-PCHRV- ADA (45 kDa) (lanes 1, 
2, respectively) fusion proteins (20µg/lane) were 
fractionated by electrophoresis through a 12.5% 
polyacrylamide SDS-gel followed by Coomassie blue staining 
(0.05%). Arrows indicate the predominant fusion protein of 
the predicted size. 
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fusion proteins. Additionally, the control and mutant MGMT 
and Ada fusion proteins were not present in affinity purified 
nontransformed ada-ogt- whole cell sonicates (data not shown) . 
The presence of purified, silver-stained cleaved fusion 
proteins (13-22 kDa) could not be demonstrated as these 
proteins presumably co-migrated on an SDS-polyacrylamide gel 
with various endogenously produced E. coli proteins. 
Therefore, purified GST-fusion proteins (or bacterial 
supernatant fractions containing GST-fusion proteins) were 
used in subsequent DNA repair studies. 
B. The Role of the 28 Amino Acid Carboxyl-Terminal Tail in 
MGMT Activity, Temperature Sensitivity, and Substrate 
Specificity 
1. Repair of 0 6 -MG in DNA by control MGMT and carboxyl-
terminal MGMT deletion proteins 
Because the MGMT 28 aa carboxyl-terminal tail is one of 
the most notable structural differences among mammalian and 
bacterial alkyl transferases, this tail may play a unique role 
in MGMT function. To determine the significance of the 
carboxyl-terminal 28 aa sequence in MGMT repair activity, a 
restriction endonuclease inhibition assay was used (Wu et 
al., 1987; Futscher et al., 1989). This assay measures the 
extent to which human MGMT, E. coli Ada, and carboxyl-
terminal MGMT deletion proteins repair 0 6 -MG lesions within 
a PvuII site (CAGCTGme) of a 32 P-end labeled, 18-bp DNA 
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Figure 12. SDS-PAGE analysis of GST-affinity purified MGMT-
ADA-MGMT GST-fusion proteins. Purified MGMT-ADAl-MGMT (48 
kDa), MGMT-ADA2-MGMT (48 kDa), MGMT-ADA3-MGMT (48 kDa), and 
MGMT-ADA5-MGMT (48 kDa) (lanes 1-4, respectively) fusion 
proteins (20µg/lane) were fractionated by electrophoresis 
through a 12.5% polyacrylamide SDS-gel followed by Coomassie 
blue staining (0.05%). Arrows indicate the purified fusion 
protein of the predicted size (positions and sizes of a Bio-
Rad SDS-PAGE low molecular weight standard are also 
indicated). 
substrate (Wu et al., 1987). 
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Preincubation of the damaged 
DNA substrate with repair proficient protein extracts allows 
for removal of the methyl group from the 0 6 -position of 
guanine. Subsequent incubation with PvuII allows cleavage of 
the DNA to generate a labeled 8-bp fragment and an unlabeled 
10-bp fragment. The 8-bp and 10-bp DNA are separated from 
the unrepaired and uncleaved 18-bp DNA containing 0 6 -MG by 
electrophoresis on a 20% denaturing polyacrylamide gel. The 
relative proportion of radiolabeled 8-nt to 18-nt DNA, after 
direct gel autoradiography, is quantitatively measured using 
a Betascope 630 (Betagen Inc.) . The amount of 
alkyltransferase activity in each protein extract is 
proportional to the ratio of 8-nt to 18-nt+B-nt DNA. 
Figure 13 represents an autoradiograph from an 
alkyltransferase assay in which the 18-bp DNA substrate was 
cleaved with PvuII following reaction with sonicates (S0µg 
total protein) of ada-ogt- cells transformed with MGMT or Ada 
cDNA constructs, encoding MGMT, MGMT-C65, MGMT-Cl0, MGMT-C28, 
or Ada fusion proteins (lanes 6-10, respectively). In this, 
and all alkyltransferase assays to be presented, the labeled 
DNA fragment, prior to protein incubation and PvuII cleavage, 
migrated as a single 18-nt labeled fragment (Figure 13, lane 
1). This DNA was completely resistant to PvuII digestion 
without prior exposure to alkyltransferase-containing protein 
sonicates (Figure 13, Lane 2) although the DNA was cleaved to 
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Figure 13. Repair of 0 6 -MG in DNA by control and truncated 
MGMT and Ada fusion proteins. Sonicates (50µg total protein) 
of ada-ogt- cells transformed with MGMT or Ada cDNA constructs 
encoding MGMT, MGMT-C65, MGMT-Cl0, MGMT-C28, or Ada fusion 
proteins (lanes 6-10, respectively) were reacted with a 32 P-
end labeled 18 bp DNA substrate (2 h, 37°C) which contains an 
O6 -MG lesion blocking a PvuII restriction enzyme recognition 
site (see figure 3). Following phenol/chloroform extraction 
and ethanol precipitation, the DNA was digested with PvuII 
(l0U, lh, 37°C). Labeled DNA fragments were analyzed for 
size on a 20% polyacrylamide gel (26 mA, 1 h) . The 8 bp 
fragment was generated by PvuII cleavage of the repaired 18 
bp fragment following incubation with MGMT or Ada fusion 
proteins. The first three control lanes are 1; unreacted, 
undigested 18 bp DNA, 2; unreacted PvuII digested 18 bp DNA, 
3; unreacted HaeIII digested 18 bp DNA. Lanes 4 and 5 
represent the PvuII digestion products of the 18bp DNA 
substrate after incubation with either non-transformed 
bacterial sonicates (50µg) or HT-29 colon carcinoma cell 
sonicates (50µg), respectively. 
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a 12-bp fragment by HaeIII which is not inhibited by the O6 -
MG lesion (Figure 13, Lane 3) . The same labeled DNA,. if 
pre-exposed to sonicates of MGMT-expressing human HT-29 colon 
carcinoma cells (Figure 13, Lane 5), sonicates of bacteria 
transformed with either MGMT cDNA constructs encoding MGMT 
(Figure 13, lane 6), MGMT-Cl0 (Figure 13, lane 8), or MGMT-
C28 (Figure 13, lane 9) or ada DNA constructs encoding Ada 
(Figure 13, lane 10), was cleaved to a labeled 8-nt fragment 
by PvuII. The presence of the 8-nt fragment is indicative of 
alkyltransferase activity 
Alkyltransferase activity, 
in these protein extracts. 
however, was absent in non-
transformed ada-ogt-cell sonicates (Figure 13, Lane 4) and in 
sonicates containing MGMT-C65 which lacks sequences encoding 
for the PCHRV acceptor site (Figure 13, lane 7) . These 
results demonstrate that up to 28 aa at the MGMT carboxyl-
terminus can be deleted without loss of MGMT activity. 
Although GST-fusion proteins were used, fusion of the GST 
peptide onto the Ada and MGMT constructs did not appear to 
affect alkyltransferase stability or repair activity. This 
observation is confirmed by the fact that the full-length 
GST-MGMT protein appeared to exhibit DNA repair activity 
comparable to that of endogenous MGMT in HT-29 colon 
carcinoma cell extracts. Additionally, based on the Ada 
crystal structure, the GST peptide appears to be fused to a 
proposed amino-terminal structural domain which is 
independent from the protein's active site. This observation 
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suggests that the GST peptide would not directly alter 
protein activity. 
2. Ouantitation of active MGMT and MGMT-C28 fusion 
proteins 
Although the carboxyl-terminal tail appears to be 
dispensable for MGMT activity, the possibility exists that 
deletion of the tail affects the rate of MGMT-mediated repair 
of 0 6 -MG in DNA. To assess this possibility, amounts of 
active purified MGMT and MGMT-C28 fusion proteins were first 
determined using an alkyltransferase activity assay in which 
1.6 pmol of fusion protein were reacted with an increasing 
pmol amount ( 1. 0-2. O) of a 32P-end labeled 18bp DNA substrate. 
At a molar excess of MGMT and MGMT-C28, MGMT activity for 
both proteins was 99% ± 3.0 (Figure 14). In this and all 
other figures, repair activity was expressed as percent 
PvuII-mediated cleavage of protein-reacted DNA relative to 
percent HaeIII-mediated cleavage (95%± 5.0) of the same DNA 
substrate. The extent of DNA substrate repair decreased, 
however, in reactions wherein the molar DNA substrate 
concentration exceeded the molar concentration of MGMT and 
MGMT-C28. The highest molar concentration of DNA substrate 
that was 100% repaired is equivalent to the molar amount of 
active fusion protein used for that given reaction. The 
quantitation of MGMT and MGMT-C28 fusion proteins by this 
functional analysis (1.3 pmol for both proteins) was in close 
-0 
~ 
-C: 
0 
(.) 
~ 0 
-
> 
-> 
-(.) 
C'il 
100 
80 
60 
40 
20 
0 
0 
I l I 
"7------r,::::\ 
\ 
-•- control 
mutant 
1.0 1.2 
V• I',, 
' 
' 
1.4 
' 
' 
' 
' 
" 'I 
~ 
' 
1.6 1.8 
DNA substrate ( pmol) 
66 
' 
' 
' 
' ,.J 
• I 
2.0 
Figure 14. Quantitation of control and mutant MGMT fusion 
proteins. MGMT (closed symbols) and MGMT-C28 (open symbols) 
fusion proteins (1.6 pmol each) were assayed for MGMT repair 
activity by reaction in triplicate with an increasing 
picomole amount (1. 0-2. 0) of a 32 P-end labeled 0 6 -MG-
containing DNA fragment for 2h at 37°c. Repair activity was 
expressed as percent PvuII-mediated cleavage of DNA substrate 
relative to HaeIII-mediated cleavage of undamaged DNA. 
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agreement with that derived by densitometric scanning of the 
Coomassie blue stained gel containing MGMT and MGMT-C28 
fusion proteins ( 1. 6 pmol) . These results indicate that 
MGMT-C28 exhibited similar activity to MGMT, and given a 
molar excess of protein, both MGMT and MGMT-C28 will 
completely repair 0 6 -MG in DNA. 
3. Effect of 28 
deletion on the rate 
containing DNA at 4°C 
amino acid carboxvl-terminal tail 
of MGMT-mediated repair of 0 6 -MG-
The repair of 0 6 -MG in DNA by MGMT and MGMT-C28 was 
determined using the restriction endonuclease inhibition 
assay. DNA repair was assessed following varying times of 
incubation of 0 6 -MG containing DNA substrate with a 100-fold 
molar excess of full-length or mutant MGMT fusion proteins at 
different temperatures. At 37°C, 2s 0c, and 15°C, repair by 
both proteins was very rapid and was complete by the first 
time point (30 s, data not shown) whereas reducing the 
reaction temperature to a randomly chosen 4°C slowed the 
reaction rate significantly. Figure 15 illustrates the 
results of an alkyltransferase assay in which a 100-fold 
molar excess (1.6 pmol) of MGMT, MGMT-C28, or Ada fusion 
proteins were incubated for varying times with the 18bp DNA 
substrate at 4°C. The Ada and MGMT fusion proteins completed 
DNA repair within 5 and 30 min, respectively, following DNA 
substrate addition. The MGMT-C28 fusion protein, however, 
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Figure 15. Effect of 28 aa carboxyl-terminal tail deletion 
on the rate of MGMT-mediated repair of O6 -MG-containing DNA 
at 4°. MGMT (closed triangles), MGMT-C28 (open triangles), 
and Ada (open circles) fusion proteins (1. 6 pmol) were 
assayed for alkyltransferase repair activity by reaction in 
triplicate with 0. 2 pmol of a 32 P-end labeled 18bp DNA 
substrate for Oto 400 min at 4°C. 
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repaired only 25% of the DNA substrate following even a 6 h 
incubation. To determine whether MGMT-C28 was permanently 
inactivated at lower temperatures, a 100-fold molar excess of 
MGMT-C28 was first reacted with the DNA substrate for 1 hat 
4°c and then for an additional hour at 37°C. Results in 
Figure 16 show that once MGMT-C28 was incubated for 1 hat 
37°c, following a 1 h 4°C incubation (Figure 16, dotted line), 
the amount of repair was comparable to that mediated by MGMT 
after 1 h at 37°C alone (Figure 16, solid line). These 
results indicate that deletion of the 28 aa carboxyl-terminal 
tail reversibly inhibits the ability of the protein to repair 
0 6 -MG in DNA at 4°C, suggesting that the carboxyl-terminal 
tail affects MGMT activity at lower temperatures. 
4. Effect of 28 
deletion on the rate 
containing DNA at 37°C 
amino acid carboxyl-terminal tail 
of MGMT-mediated repair of 0 6 -MG-
Because of the temperature sensitive nature of the MGMT-
C28 fusion protein, the rates of repair of 0 6 -MG in DNA by 
MGMT and MGMT-C28 were assessed using a 37°C incubation and 
a 10-fold decreased molar concentration of protein:DNA 
substrate, which in turn slowed the reaction and allowed 
accurate assessment of the time course of repair. Using 
these conditions, the MGMT and MGMT-C28 fusion proteins had 
equivalent rates of repair of 0 6 -MG in DNA. Both proteins 
repaired approximately 25% of the substrate within 5 min and 
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Figure 16. Analysis of the temperature sensitivity of the 
MGMT-C28 mutant fusion protein. MGMT (1.6 pmol) (solid line) 
was assayed for MGMT activity by reaction in triplicate with 
0.02 pmol of a 32 P-end labeled 18bp DNA substrate for o, 60, 
and 120 min at 37°C. MGMT-C28 (1.6 pmol) (dotted line) was 
assayed for MGMT activity by reaction with 0.2 pmol of a 32P-
end labeled 18bp DNA substrate for o min at 4°c, 60 min at 4°C 
and then an additional 60 min at 37°C, and for 120 min at 4°C. 
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Figure 17. Effect of 28 aa carboxyl-terminal tail deletion 
on the rate of MGMT-mediated repair of 0 6 -MG-containing DNA 
at 37°C. MGMT (closed symbols) and MGMT-C28 (open symbols) 
fusion proteins ( 1. 6 pmol) were assayed for MGMT repair 
activity by reaction in triplicate with 0.002 pmol of a 32 P-
end labeled 18bp DNA substrate for Oto 30 min at 37°C. 
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100% of the substrate within 30 min (Figure 17) . These 
results indicate that the rate of MGMT-mediated repai~ of 
0 6MG in DNA at 3 7°C is not affected by deletion of the 
carboxyl-terminal tail. 
5. Effect of 28 amino acid carboxyl-terminal tail 
deletion on the rate of MGMT-mediated repair of 0 6 -BG 
While the tail sequence appears to be absolutely 
dispensable for MGMT-mediated repair of 0 6 -MG in DNA, the 
possibility exists that divergent regions such as the 
carboxyl-terminal tail may play a role in alkyltransferase 
substrate specificity. Specifically, this carboxyl-terminal 
tail, which is lacking in Ada, may uniquely contribute to the 
ability of MGMT to repair larger, bulkier lesions such as 0 6 -
BG. To assess the role the tail plays in 0 6 -BG repair, MGMT, 
MGMT-C28, and Ada fusion proteins, and HT-29 cell sonicates 
containing endogenous MGMT protein, were indirectly analyzed 
for the rates of repair of 0 6 -BG. These proteins (1.6 pmol) 
were incubated for varying times with a 10-fold molar excess 
of 0 6 -BG followed by the addition of the 18-bp DNA substrate 
previously described. The ability of the various proteins to 
repair 0 6 -BG was measured as inhibition of the repair of 0 6 -MG 
in DNA by BG pre-incubation using the restriction 
endonuclease inhibition assay. As described previously 
(Dolan et al., 1991) , Ada, which served as a negative 
control, was unaffected by 0 6 -BG pre-exposure (Figure 18, 
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Figure 18. Effect of 28 aa carboxyl-terminal tail deletion 
on the rate of MGMT-mediated repair of 0 6 -BG. MGMT (closed 
triangle}, MGMT-C28 (open triangle}, and Ada (open circle) 
fusion proteins (1.6 pmol} and an equimolar amount of 
endogenous MGMT (closed circles} in HT-29 colon carcinoma 
cell sonicates were reacted in triplicate with 16 pmol of 0 6 -
BG for Oto 10 min at 37°C. These proteins were subsequently 
incubated with the 18bp DNA substrate for 2 h. 0 6 -BG 
mediated inhibition of 0 6 -MG repair was monitored by the 
restriction endonuclease inhibition assay as described in 
figure 13. 0 6 -BG-mediated inactivation was expressed as 
percent inhibition of PvuII-mediated cleavage of the protein-
reacted DNA relative to non-PvuII-digested DNA. 
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0-12 min). In contrast, MGMT-expressing HT-29 cell sonicates 
(l0µg), serving as a positive control, were partially 
inactivated {as measured by inhibition of PvuII-mediated 
cleavage of the protein-reacted DNA, relative to non-PvuII 
digested DNA) within seconds of 0 6 -BG exposure {Figure 18, 0 
time point), and were completely inactivated within 2 min. 
The time course of 0 6 -BG inactivation of the MGMT fusion 
protein was similar to that of the human MGMT in cell 
extracts with both proteins being completely inactivated 
within 2 min. The rate of 0 6 -BG-mediated inactivation of 
MGMT-C28 was, however, different from that of the MGMT fusion 
protein. Although both proteins were completely inactivated 
by 0 6 -BG within 10 min, the rate of inactivation of MGMT-C28 
compared to MGMT was decreased at least 5-fold {Figure 18), 
as measured by the 0 6 -BG exposure necessary to cause 50% 
inactivation (2 min for MGMT-C28 and <30 s for MGMT). These 
results indicate that deletion of the MGMT 28 aa carboxyl-
terminal tail decreases the rate of MGMT-mediated repair of 
0 6 -BG, suggesting that the carboxyl-terminal tail plays an 
indirect role in MGMT-mediated 0 6 -BG repair activity. 
6. Repair of 0 6 -BG by ADA-MGMTTAIL fusion protein 
The exact mechanism by which the carboxyl-terminal tail 
affects the rate of 0 6 -BG repair is unknown although it is 
possible that this tail may indirectly affect the formation 
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0 f the MGMT active site structure needed to properly orient 
MGMT around bulkier molecules such as 0 6 -BG. In this case, 
repair of 0 6 -BG by a full-length Ada fused to the carboxyl-
terminal tail may be expected to occur assuming the ability 
of the tail alone to alter the formation of Ada's active site 
pocket in such a way as to allow for binding to 0 6 -BG. To 
address this possibility, active purified MGMT, Ada, and ADA-
MGMTTAIL fusion proteins (1.6 pmol) were analyzed for their 
ability to repair 0 6 -BG by incubating these proteins with a 
10-fold molar excess of 0 6 -BG for varying times. These 
proteins were subsequently incubated with the 18-bp DNA 
substrate for 2 h. 0 6 -BG mediated inhibition of 0 6 -MG repair 
was assessed using the restriction endonuclease inhibition 
assay. Ada and ADA-MGMTTAIL were unaffected by 0 6 -BG pre-
exposure (100µ,M) (Figure 19, 0-10 min) whereas MGMT was 
completely inactivated within 2 min. The inability of ADA-
MGMTTAIL to repair 0 6 -BG indicates that the MGMT 28 aa 
carboxyl-terminal tail alone is insufficient to alter Ada's 
active site in such a way as to facilitate the repair of 0 6 -
BG. 
C. Analysis of MGMT Amino Acids Required for the Repair of 
0 6 -MG in DNA 
To identify the minimum aa sequence required for MGMT 
repair activity, a series of MGMT oligopeptides and amino- or 
carboxyl-terminal MGMT deletion proteins were assessed for 
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Figure 19. Analysis of repair of 0 6 -BG by the ADA-MGMTTAIL 
fusion protein. MGMT ( closed triangle) , Ada ( closed circle) , 
and ADA-MGMTTAIL (open triangle) fusion proteins (1.6 pmol) 
were reacted in triplicate with 16 pmol of 0 6 -BG for 0-10 min 
at 37°C. These proteins were subsequently incubated with a 
32P-end-labeled 0 6 -MG-containing DNA substrate for 2 h. 0 6 -
BG-mediated inhibition of 0 6 -MG repair was monitored by the 
restriction endonuclease inhibition assay as described in 
figure 13. 
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Figure 20 . Repair of 0 6 -MG in DNA by control and truncated 
MGMT fusion proteins and oligopeptides . Sonicates (S0µg of 
total protein) of nontransformed ada-ogt- cells (lane 4) or 
of ada-ogt- cells transformed with MGMT cDNA constructs 
encoding either MGMT-C65, MGMT, MGMT-C35, MGMT-Nl8, or MGMT -
N78 fusion proteins (lanes 5-9, respectively) or 25µg of 
purified MGMT Peptide 1, Peptide 2, Peptide 3, or Peptide 4 
(lanes 10-13, respectively) were analyzed in triplicate for 
alkyltransferase repair activity using the restriction 
endonuclease inhibition assay as described in Figure 13 . 
their ability to repair 0 6 -MG in DNA. 
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Figure 20 represents 
an autoradiograph from an alkyltransferase assay in which 
the 32 P-end-labeled 0 6 -MG-containing 18-bp DNA substrate was 
cleaved with PvuII following reaction with sonicates 
containing 50µg of total protein. Sonicates of ada-ogt- cells 
transformed with MGMT cDNA constructs encoding either MGMT-
C65, MGMT, MGMT-C35, MGMT-N18, or MGMT-N78 fusion proteins or 
25 µg of purified MGMT Peptide 1, Peptide 2, Peptide 3, or 
Peptide 4 (lanes 5-13, re spec ti vely) were assayed. 
Alkyltransferase activity was present in sonicates containing 
MGMT (Figure 20, lane 6) but was absent in nontransformed 
ada-ogt- cell sonicates (Figure 20, lane 4) and in sonicates 
containing MGMT-C65 which lacks sequences encoding the PCHRV 
acceptor site (Fig 16, lane 5). MGMT Peptides 1-4 (Figure 
20, lanes 10-13, respectively), which do contain the PCHRV 
acceptor site, were also inactive. Additionally, sonicates 
of bacteria transformed with MGMT cDNA constructs encoding 
MGMT-C35, MGMT-N18, or MGMT-N78 (Figure 20, lanes 7,8,9, 
respectively) did not contain detectable levels of 
alkyltransferase activity. Furthermore, none of the MGMT 
mutant fusion proteins or oligopeptides were able to repair 
0 6 -MG in DNA even upon prolonged exposure (18 h) of the DNA 
substrate in a 50-fold molar protein excess (data not shown). 
Truncation of MGMT did not, however, appear to affect protein 
expression or stability since all purified deletion mutants 
were expressed at levels comparable to the wildtype protein 
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and were of the predicted size as demonstrated by SDS-PAGE 
analysis. 
While studies of MGMT oligopeptides and deletion 
proteins suggest that nearly the entire MGMT protein is 
required for 0 6 -MG repair in DNA, the possibility exists that 
these mutants are capable of repairing 0 6 -MG in DNA, but have 
lost sequences which allow for the interaction of the protein 
with DNA prior to DNA repair. In this scenario, repair by 
the MGMT deletion fusion proteins and oligopeptides would be 
expected to be low or absent given the inability of these 
proteins to interact with the substrate in anything but a 
random fashion. To address this possibility, deletion MGMT 
fusion proteins and oligopeptides were analyzed for their 
ability to repair a damaged free base. Although 0 6 -MG is a 
logical choice, the free base chosen, 0 6 -BG, is a better 
substrate for MGMT being repaired 1000-fold more efficiently 
than the free base 0 6 -MG (Dolan et al., 1991). Since repair 
of 0 6 -BG by even the wildtype MGMT is independent of DNA 
interaction, truncated MGMT proteins and oligopeptides 
capable of repair but incapable of DNA binding, would be 
expected to repair this substrate. As shown in Table 1, 
incubation of bacterial sonicates containing an approximate 
100-fold molar excess of the full-length MGMT fusion protein 
with 8- [3H] -06 -benzylguanine 
conversion to 8-[ 3H]guanine 
produced 
(99.5%±1.5) 
nearly complete 
as measured by 
reverse phase HPLC separation of the compounds. In contrast, 
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Table 1. Analysis of 0 6 -BG repair activity by control MGMT, 
Ada, or truncated MGMT fusion proteins and oligopeptides. 
Protain 
MGMT 
Ada 
ada· ogf 
MGMT-N18 
MGMT-N78 
MGMT-C35 
Peptide 1 
Peptide 2 
Peptide 3 
Peptide 4 
%~Guanine formed 
99.5 :t 1.5 
0.0 :t 1.0 
0.0 :1: 1.0 
0.0 :1: 2.0 
0.2 ± 2.0 
0.0 ± 1.0 
0.2 :t 1.5 
0.0 ± 1.0 
0.2 :t 1.2 
0.2 ± 1.5 
%BG(\.4] 
0.5 ± 1.5 
100.0 ± 1.0 
100.0 ± 1.0 
100.0 ± 2.0 
99.8 ± 2.0 
100.0 ± 1.0 
99.8 ± 1.5 
100.0 ± 1.0 
99.8 ± 1.2 
99.8 ± 1.5 
11. 5 pmol of 8- [3H] -06-benzylguanine were incubated in 
triplicate with a 100-fold molar excess of MGMT, Ada, MGMT-
N18, MGMT-N78, and MGMT-C35 fusion proteins and MGMT Peptides 
1-4 for 2 hat 37°C. Measurements of 8- [3H]guanine formation 
from 8- [3H] -06 -benzylguanine for each sample were determined 
by reverse phase HPLC separation of the compounds. A control 
incubation of non-transformed ada-ogt- bacterial sonicates 
(50µg) with the 0 6 -BG substrate was carried out for the same 
time in the same buffer. 
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incubation of the 0 6 -BG substrate with ada-ogt- bacterial 
sonicates produced no significant 8- [3H]guanine (0.0% ±1.0). 
Sonicates containing an estimated 100-fold molar excess of 
either ADA, MGMT-N18, MGMT-N78, or MGMT-C35 fusion proteins 
and MGMT Peptides 1-4 also mediated no significant repair of 
Combined with the results from figure 20, these 
studies demonstrate that the 22 aa immediately surrounding 
the PCHRV acceptor site alone are insufficient for 0 6 -MG 
repair in DNA and, in connection with the carboxyl- and 
amino-terminal deletion analyses, suggest that 0 6 -MG repair 
in DNA requires nearly the entire protein. Furthermore, 
results from Table 1 suggest that the inability of the above 
described MGMT oligopeptides and deletion fusion proteins to 
repair 0 6 -MG-containing DNA is not merely due to an inability 
to interact with DNA, but to an inability to recognize and/or 
repair guanine damaged at the 0 6-position as a free base or 
in the context of DNA. These studies, therefore, suggest 
that MGMT functions as a single domain protein responsible 
for DNA repair activity. 
D. Analysis of MGMT Amino Acid Regions Involved in 0 6 -
Benzylguanine Substrate Specificity 
1. Repair of 0 6 -MG in DNA by control MGMT, Ada, or MGMT-
ADA and ADA-MGMT chimeric fusion proteins 
While analysis of aa involved in MGMT-mediated repair of 
0 6 -MG in DNA contributes to a better understanding of how 
alkyltransferases function, an understanding of how MGMT 
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differentially interacts with various lesions such as O6 -BG 
is lacking. The identification, therefore, of MGMT aa 
potentially involved in O6 -BG substrate specificity has been 
accomplished by assessing the ability of a series of chimeric 
proteins containing both MGMT and Ada sequences to repair O6 -
BG. Prior to the assessment of MGMT aa regions involved in 
the differential repair of O6 -BG, however, MGMT-ADA and ADA-
MGMT chimeras were first analyzed to verify their ability to 
repair O6 -MG in DNA. The ADA-PCHRV-MGMT and MGMT-PCHRV-ADA 
chimeric fusion proteins, consisting of MGMT and Ada 
sequences fused at the PCHRV acceptor site, were constructed 
to analyze the role of sequences carboxyl-terminal to the 
PCHRV acceptor site in O6 -BG repair. The ADA-LELS-MGMT and 
MGMT-GLHE-ADA chimeric proteins, consisting of MGMT and Ada 
sequences fused at the MGMT amino-terminal LELS or GLHE 
sequences, respectively, were constructed to analyze the role 
of sequences amino-terminal to the PCHRV acceptor site in O6 -
BG repair. To determine whether these chimeras are active 
proteins, an alkyltransferase activity assay was used. 
Figure 21 represents an autoradiograph from an 
alkyltransferase assay in which the 32 P-end-labeled O6 -MG-
containing 18-bp DNA substrate was cleaved with PvuII 
following reaction with sonicates (S0µg of total protein) of 
non-transformed ada-ogt- cells or of ada-ogt- cells 
transformed with MGMT, ada, or chimeric cDNA constructs 
encoding either MGMT, Ada, ADA-PCHRV-MGMT, or MGMT-PCHRV-ADA 
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fusion proteins. Alkyltransferase activty was absent in non-
transformed ada-ogt- cell sonicates (Figure 21, lane 4) _but 
was present in sonicates containing MGMT, Ada, ADA-PCHRV-
MGMT, or MGMT-PCHRV-ADA fusion proteins (Figure 21, lanes 5-
8, respectively). These results demonstrate that 
alkyltransferases from divergent evolutionary backgrounds can 
be fused together at the PCHRV acceptor site and still remain 
active, suggesting that the protein conformation which 
mediates 0 6 -MG repair is comparable or at least complementary 
in both proteins. As described in section B, the unique MGMT 
28 aa carboxyl-terminal tail is not required for MGMT 
activity as demonstrated by the ability of the MGMT-PCHRV-ADA 
protein, which lacks the tail, to repair 0 6 -MG in DNA. The 
aa region between the PCHRV acceptor site and the MGMT 
carboxyl-terminal tail, however, is necessary for activity as 
demonstrated (in section C) by the inability of the MGMT-C35 
deletion mutant to repair 0 6 -MG-containing DNA. This region, 
however, appears to be functionally interchangeable between 
the bacteria and human alkyltransferases as both MGMT-PCHRV-
ADA and ADA-PCHRV-MGMT fusion proteins exhibited DNA repair 
activity. The activity of chimeric proteins fused at amino-
terminal sequences was also determined using a similar 
alkyltransferase activity assay in which the 18-bp DNA 
substrate was reacted with increasing µg amounts of total 
protein (0-200µg) derived from sonicated, IPTG-induced 
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Figure 21. Repair of O6 -MG in DNA by control MGMT, Ada, or 
MGMT-PCHRV-ADA, and ADA-PCHRV-MGMT fusion proteins. 
Sonicates (S0µg of total protein) of nontransformed ada-ogt-
cells (lane 4) or of ada-ogt- cells transformed with MGMT, 
Ada, or chimeric cDNA constructs encoding either MGMT, Ada, 
ADA-PCHRV-MGMT, or MGMT-PCHRV-ADA fusion proteins (lanes 5-8, 
respectively) were analyzed in triplicate for 
alkyltransferase repair activity using the restriction 
endonuclease inhibition assay as described in Figure 13. 
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bacteria containing either ADA-LELS-MGMT or MGMT-GLHE-ADA 
fusion proteins. Alkyltransferase activity was reaqily 
detectable using as little as 2µg total protein bacterial 
sonicates containing ADA-LELS-MGMT or MGMT-GLHE-ADA fusion 
proteins (Figures 22 and 23, respectively). The repair of 
O6 -MG-containing DNA substrate by these proteins increased to 
23%± 5. 0 of control values when Sµg ADA-LELS-MGMT total 
protein (Figure 22) or l0µg MGMT-GLHE-ADA total protein 
(Figure 23) was used. Both chimeric proteins, however, 
exhibited only a 30% maximal repair capacity relative to the 
control MGMT, even when up to 200µg of the protein were 
assayed. This minimal repair was not likely due to the 
instability of the proteins since all fusion mutants were 
expressed to levels comparable to the wildtype and were of 
the predicted size as demonstrated by SDS-PAGE analysis. 
Combined with the results from figure 21 these studies 
demonstrate that while some aa sequences which mediate 
protein activity are complementary in both proteins, the 
amino-terminal regions of MGMT and Ada contain non-
interchangeable aa that, if replaced, alter the ability of 
the protein to repair O6 -MG in DNA. 
2. Quantitation of active control and chimeric Ada and 
MGMT fusion proteins 
To identify MGMT aa regions involved in the differential 
repair of O6 -BG, amounts of active purified chimeric fusion 
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Figure 22. Repair of 0 6 -MG in DNA by ADA-LELS-MGMT chimeric 
fusion protein. Sonicates containing ADA-LELS-MGMT fusion 
proteins (0-200µg total protein) were assayed for 
alkyltransferase repair activity by reaction in triplicate 
with a 32 P-end-labeled 0 6 -MG-containing DNA substrate for 2 h 
at 37°c. 
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Figure 23. Repair of 0 6 -MG in DNA by MGMT-GLHE-ADA chimeric 
fusion protein. Sonicates containing MGMT-GLHE-ADA fusion 
proteins (0-200µg total protein) were assayed for 
alkyltransferase repair activity by reaction in triplicate 
with a 32 P-end-labeled 0 6 -MG-containing DNA substrate for 2 h 
at 37°c. 
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protein were first determined using an alkyltransferase 
activity assay in which 1.6 pmol of MGMT, MGMT-PCHRV-ADA, 
Ada, or ADA-PCHRV-MGMT fusion protein (as determined by 
densitometric scanning of the Coomassie blue stained gel 
containing the control and chimeric MGMT and Ada fusion 
proteins) were reacted with 1.0-2.2 pmol of 32 P-end-labeled 
0 6 -MG-containing DNA. Lack of complete repair by ADA-LELS-
MGMT and MGMT-GLHE-ADA (Figures 22 and 23) prohibited 
quantitation of active proteins and, therefore, all 
subsequent studies with these proteins were carried out using 
bacterial sonicates containing SOµg total protein. At a 
molar excess of MGMT, MGMT-PCHRV-ADA, Ada and ADA-PCHRV-MGMT, 
alkyltransferase activity (expressed as percent PvuII-
mediated cleavage of protein-reacted DNA relative to HaeIII-
mediated cleavage of the same DNA substrate) was essentially 
100% for all proteins (data not shown). The highest molar 
concentration of DNA substrate that was 100% repaired is 
equivalent to the molar amount of active fusion protein used 
for that given reaction. The quantitation of chimeric 
proteins by this functional analysis (1.4-1.5 pmol for all 
proteins) (data not shown) was in close agreement with that 
derived by densitometric scanning and Bradford analysis (1.6 
pmol). These results indicate that all chimeric proteins 
exhibited similar activity to MGMT and Ada and given a molar 
excess of protein, all chimeras will completely repair 0 6 -MG 
in DNA. 
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3. Repair of 0 6 -BG by MGMT-ADA and ADA-MGMT chimeric 
fusion proteins 
To identify aa involved in MGMT-selective repair of 0 6 -
BG, MGMT, Ada, MGMT-PCHRV-ADA, or ADA-PCHRV-MGMT chimeric 
fusion proteins were indirectly analyzed for the rates of 
repair of 0 6 -BG by incubating these chimeric proteins (1.6 
pmol) for varying times with a 10-fold molar excess of 0 6 -BG 
followed by the addition of the 18-bp DNA substrate 
previously described. The ability of the various proteins to 
repair 0 6 -BG was measured as inhibition of the repair of 0 6 -MG 
in DNA by 0 6 -BG pre-incubation using the restriction 
endonuclease inhibition assay. MGMT was partially 
inactivated within seconds of 0 6 -BG exposure (Figure 24, O 
time point) and was completely inactivated (as measured by 
inhibition of PvuII-mediated cleavage of the protein-reacted 
DNA, relative to non-PvuII-digested DNA) within 2 min. The 
time course of 0 6 -BG repair by the MGMT-PCHRV-ADA fusion 
protein was similar to the full-length MGMT with both 
proteins being completely inactivated by 0 6 -BG within 2 min 
(Figure 24) although pre-incubation for various times without 
0 6 -BG did not affect protein activity. Ada and ADA-PCHRV-
MGMT fusion proteins, however, were insensitive to 0 6 -BG 
inhibition (Figure 24) Furthermore, ADA-PCHRV-MGMT, when 
incubated with a 10-fold molar excess of 0 6 -BG for a 
prolonged time (30 min), still remained BG insensitive (data 
not shown). Therefore, although both MGMT-PCHRV-ADA and ADA-
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Figure 24. Analysis of repair of 0 6 -BG by the MGMT-PCHRV-
ADA and ADA-PCHRV-MGMT chimeric fusion proteins. MGMT (open 
square), Ada (closed circle), MGMT-PCHRV-ADA (closed 
triangle), and ADA-PCHRV-MGMT (open triangle) purified fusion 
proteins (1.6 pmol) were reacted in triplicate with 16 pmol 
of 0 6 -BG for 0-10 min at 37°C. These proteins were 
subsequently incubated with a 32 P-end-labeled 0 6 -MG-containing 
DNA substrate for 2 h. 0 6 -BG repair was measured as 
inhibition of the repair of 0 6 -MG in DNA by 0 6 -BG pre-
incubation using the restriction endonuclease inhibition 
assay as described in figure 13. 
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PCHRV-MGMT share the same PCHRV acceptor site, and both 
repair O6 -MG-containing DNA, only MGMT-PCHRV-ADA repaired O6 -
BG, suggesting that sequences amino terminal to the PCHRV 
acceptor site contribute to MGMT-mediated repair of O6 -BG. 
This finding is further supported by analysis of O6 -BG repair 
by non-purified ADA-LELS-MGMT and MGMT-GLHE-ADA which are 
fused at amino-terminal regions. As described, both proteins 
repaired O6 -MG in DNA but to a lesser extent (30%) than the 
control Ada or MGMT fusion proteins. This activity, however, 
was eliminated by pre-incubation of ADA-LELS-MGMT with l00µM 
O6 -BG for varying times (Figure 25) although pre-incubation 
for various times without O6 -BG did not affect protein 
activity. In contrast, repair of O6 -MG-containing DNA by 
MGMT-GLHE-ADA was unaffected by O6 -BG pre-exposure (Figure 
25, 0-10 min), suggesting that MGMT aa between the amino-
terminal GLHE region and the PCHRV acceptor site (aa 27-148) 
are involved in the differential repair of O6 -BG. 
4. Repair of O6 -BG by MGMT-ADA-MGMT chimeric fusion 
proteins 
To further define which MGMT aa region or regions are 
involved in O6 -BG substrate specificity, a series of MGMT-
ADA-MGMT chimeric proteins, which as a whole contain Ada aa 
regions in place of MGMT aa regions 1, 2, 3, and 5 (Figure 
26), were analyzed for their ability to repair O6 -MG in DNA 
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Figure 25. Analysis of repair of 0 6 -BG by the ADA-LELS-MGMT 
and MGMT-GLHE-ADA chimeric fusion proteins. ADA-LELS-MGMT 
(closed circle) and MGMT-GLHE-ADA (open triangle) non-
purified fusion proteins (S0µg) were reacted in triplicate 
with a 100-fold molar excess of 0 6 -BG for 0-10 min at 37°C. 
These proteins were subsequently incubated with a 32 P-end-
labeled 0 6 -MG-containing DNA substrate for 2 h. 0 6 -BG repair 
was measured as inhibition of the repair of 0 6 -MG in DNA by 
0 6 -BG pre-incubation using the restriction endonuclease 
inhibition assay as described in figure 13. 
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and 0 6 -BG using the restriction endonuclease inhibition 
assay. Figure 27 (lanes 1-10) represents an autoradiograph 
from an alkyltransferase activity assay in which the 18-bp 
DNA substrate was cleaved with PvuII following reaction with 
sonicates (SOµg total protein) of non-transformed ada-ogt-
cells or of ada-ogt- cells transformed with MGMT, ada, or 
chimeric cDNA constructs encoding MGMT, Ada, MGMT-ADAl-MGMT, 
MGMT-ADA2-MGMT, MGMT-ADA3-MGMT, or MGMT-ADAS-MGMT fusion 
proteins. Alkyltransferase activity was present in sonicates 
containing MGMT, Ada, MGMT-ADAl-MGMT, MGMT-ADA2-MGMT, MGMT-
ADA3-MGMT, or MGMT-ADAS-MGMT fusion proteins (Figure 27, 
lanes 4, S and 7-10, respectively) but was absent in non-
transformed ada-ogt- cell sonicates (Figure 27, lane 6). All 
repair proficient MGMT-ADA-MGMT proteins were 
subsequently analyzed for the repair of 0 6 -BG by pre-
incubating these chimeric proteins with an estimated 10-fold 
molar excess of 0 6 -BG for 30 min followed by the addition of 
the 0 6 -MG-containing 18-bp DNA substrate for an additional 2 
h. 0 6 -BG mediated inhibition of 0 6 -MG repair was assessed 
using the restriction endonuclease inhibition assay. MGMT, 
MGMT-ADAl - MGMT, MGMT-ADA2 - MGMT, MGMT-ADA3 - MGMT, and MGMT-
ADAS - MGMT were all inactivated by 0 6 -BG pre-exposure as shown 
by the lack of alkyltransferase activity in sonicates 
containing these chimeras (Figure 27, lanes 11 and 13-16, 
respectively) although pre-incubation for 30 min without 0 6 -
BG did not affect chimeric protein activity (data not shown). 
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Figure 26. Summary diagram of the construction of MGMT-ADA-
MGMT chimeric proteins. MGMT-ADA-MGMT chimeric fusion 
proteins contain Ada aa in place of either MGMT aa region 1 
(MGMT-ADAl-MGMT), MGMT aa region 2 (MGMT-ADA2-MGMT), MGMT aa 
region 3 (MGMT-ADA3-MGMT), or MGMT aa region 5 (MGMT-ADAS-
MGMT). MGMT aa regions 1-5 (bold lines) span from the MGMT 
amino-terminal GLHE region to the PCHRV acceptor site 
(bordered by arrows). Alignment of the numbered MGMT aa is 
according to Santibanez-Koref et al., 1992. 
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Figure 27. Repair of 0 6 -MG in DNA and 0 6 -BG by control MGMT, 
Ada, and MGMT-ADA- MGMT chimeric fusion proteins. Sonicates 
(50µg total protein) of non-transformed ada-ogt- cells (lane 
6) or of ada-ogt- cells transformed with MGMT, ada, or 
chimeric cDNA constructs encoding either MGMT, Ada, MGMT-
ADAl-MGMT, MGMT-ADA2-MGMT, MGMT-ADA3-MGMT, or MGMT-ADAS-MGMT 
fusion proteins (lanes 4, 5, and 7-10, respectively) were 
analyzed in triplicate for alkyltransferase repair activity 
using the restriction endonuclease inhibition assay as 
described in figure 13. Sonicates (50µg total protein) of 
ada-ogt- cells transformed with MGMT , ada, or chimeric cDNA 
constructs encoding either MGMT, Ada, MGMT-ADAl-MGMT, MGMT-
ADA2-MGMT, MGMT-ADA3-MGMT, or MGMT-ADAS-MGMT fusion proteins 
(lanes 11-16, respectively) were reacted in triplicate with 
a 10 - fold molar excess of 0 6 -BG for 30 min followed by the 
addition of the 32P-end-labeled 0 6 -MG-containing DNA substrate 
for an additional 2 h. 0 6 -BG repair was measured as 
inhibition of the repair of 0 6 -MG in DNA by 0 6 -BG pre-
incubation using the restriction endonuclease inhibition 
assay. 
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In contrast, Ada was proficient at the repair of 0 6 -MG in DNA 
even after 0 6 -BG exposure (Figure 27, lane 12). The ability 
of all MGMT-ADA-MGMT chimeras to repair 0 6 -BG suggests that 
MGMT aa regions 1, 2, 3, and 5 alone (Figure 26) are not 
involved in MGMT-mediated repair of 0 6 -BG. By inference, 
therefore, the unique ability of MGMT to interact with 0 6 -BG 
appears to reside in any of 49 aa spanning three MGMT aa 
regions amino-terminal to the PCHRV acceptor site (Figure 
28) . 
E. Comparison of Ada Amino Acid Regions Involved in 0 4 -
Methylthymine Substrate Specificity to that of MGMT Amino 
Acid Regions Involved in 0 6 -Benzylguanine Substrate 
Specificity 
Differences in MGMT and Ada substrate specificity can be 
further defined by comparing Ada aa regions involved in the 
repair of 0 4 -MT in DNA to MGMT aa regions involved in the 
repair of 0 6 -BG. The differences between MGMT and Ada in the 
repair of 0 6 -BG and 0 4 -MT may be accounted for by a few common 
aa changes within MGMT and Ada or, alternatively, MGMT and 
Ada may differ significantly in the conformation of their 
active sites such that different aa regions account for MGMT-
mediated repair of 0 6 -BG and Ada-mediated repair of 0 4 -MT. 
To compare aa regions involved in 0 6 -BG substrate specificity 
to those involved in 0 4 -MT substrate specificity, MGMT, Ada, 
MGMT-PCHRV-ADA, or ADA-PCHRV-MGMT fusion proteins (100-fold 
molar excess) were analyzed for their ability to repair 0 4 -
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Figure 28. Summary diagram of MGMT aa regions potentially 
involved in MGMT-mediated repair of 0 6 -BG. Solid black lines 
indicate 0 6 -BG specificity sites. The PCHRV acceptor site is 
marked by the boxed area. Alignment of the numbered MGMT aa 
is according to Santibanez-Koref et al., 1992. 
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methyl [3H] thymine ( approximately 0. 5 pmol) in poly ( dA) -
poly (dT) substrate. O4 -MT repair was assessed by compar_ing 
O4 -methyl[ 3H]thymine content in poly(dA)-poly(dT) exposed to 
full-length or chimeric MGMT and Ada proteins to that in 
control poly(dA)-poly(dT) substrate. As described 
previously, (Dolan et al., 1984) Ada significantly reduced 
O4 -MT content relative to incubations containing polymer 
alone as measured by reverse phase HPLC (Table 2). 
Furthermore, the repair was specific for O4 -MT as no change 
was observed in 3-methylthymine content following protein 
incubation. There was no significant repair of O4 -MT, 
however, when MGMT, MGMT-PCHRV-ADA, and ADA-PCHRV-MGMT were 
incubated with the O4 -methyl[ 3H]thymine-containing poly(dA)-
poly(dT) substrate, suggesting that sequences surrounding 
PCHRV are relevant to Ada-mediated O4 -MT repair. In a 
parallel experiment in which the same protein preparations 
and buffer conditions were used, all proteins were analyzed 
for their ability to repair O6 -MG in DNA using the 
alkyltransferase assay. Figure 29 represents an 
autoradiograph from an alkyltransferase activity assay in 
which the 18-bp DNA substrate was cleaved with PvuII 
following reaction with sonicates of non-transformed ada-ogt-
cells or of ada-ogt- cells transformed with MGMT, Ada, or 
chimeric cDNA constructs encoding Ada, MGMT, ADA-PCHRV-MGMT, 
or MGMT-PCHRV-ADA fusion proteins. Alkyltransferase activity 
was present only in sonicates containing Ada, MGMT, ADA-
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PCHRV-MGMT, or MGMT-PCHRV-ADA fusion proteins (Figure 29, 
lanes 5-8, respectively) . These results clearly indic_ate 
that MGMT, MGMT-PCHRV-ADA, and ADA-PCHRV-MGMT do not repair 
0 4 -MT under conditions in which 0 6 -MG is repaired rapidly. 
While MGMT sequences potentially involved in 0 6 -BG repair 
include aa amino-terminal to the PCHRV acceptor site, aa 
involved in Ada-selective repair of 0 4 -MT are both amino- and 
carboxyl-terminal to the PCHRV acceptor site. These studies 
exclude the possibility that a few common aa changes within 
MGMT and Ada can account for both 0 4 -MT and 0 6 -BG repair 
capacities. Instead, MGMT and Ada may differ significantly 
in the conformation of their active sites such that different 
aa regions within MGMT and Ada define the overall substrate 
specificity of the proteins. 
100 
Table 2. Repair of 0 4 -MT in DNA by MGMT-PCHRV-ADA and ADA-
PCHRV-MGMT chimeric fusion proteins. 
PROTEIN 
NONE 
ADA 
MGMT 
ADA-PCHRV-MGMT 
MGMT-PCHRV-ADA 
METHYLATED BASES REMAINING IN SUBSTRATE C PMOL l 
3-METHYLTHYMINE 
0.60 ±0.03 
0.60 ±0.02 
0.63 ±0.01 
0.55 ±0.02 
0.58 ±0.01 
O'-METHYLTHYMINE 
0.49 ±0.01 
0.02 ±0.03 
0.45 ±0.06 
0.45 ±0.05 
0.47 ±0.02 
N-[ 3H]methyl-N-nitrosourea-exposed poly(dA)-poly(dT) 
substrate containing 0. 5 pmol 0 4 -methyl [3H] thymine and 0. 6 
pmol 3-methyl[ 3 ]thymine was incubated in triplicate with a 
100-fold molar excess of MGMT, Ada, MGMT-PCHRV-ADA, or ADA-
PCHRV-MGMT fusion proteins for 2 h at 37°C. A control 
incubation without added protein was carried out for the same 
time in the same buffer. 0 4 -MT repair was determined by 
comparing 0 4 -methyl[ 3H]thymine content in poly(dA)-poly(dT) 
exposed to full-length or chimeric MGMT and Ada proteins to 
that in control poly(dA)-poly(dT) substrate as measured by 
reverse phase HPLC. 
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Figure 29. Repair of 0 6 -MG in DNA by control MGMT, Ada, 
ADA-PCHRV-MGMT, or MGMT-PCHRV-ADA fusion proteins . 
Sonicates (50µg of total protein) of nontransformed ada-ogt-
cells (lane 4) or of ada-ogt- cells transformed with Ada, 
MGMT, or chimeric cDNA constructs encoding Ada, MGMT, ADA-
PCHRV-MGMT, or MGMT-PCHRV-ADA fusion proteins (lanes 5-8, 
respectively) were analyzed in triplicate for 
alkyltransferase repair activity using the restriction 
endonuclease inhibition assay as described in Figure 13. 
CHAPTER V 
DISCUSSION 
While DNA repair by all alkyltransferases depends upon 
an essential acceptor cysteine located within the highly 
conserved PCHRV acceptor site, very little else is known 
concerning the contribution of other aa, both conserved and 
divergent, in alkyl transferase folding, stability, repair 
activity, and substrate specificity. The importance of the 
PCHRV acceptor site and other surrounding aa in 
alkyltransferase function, however, has been recently 
demonstrated by site-directed mutagenesis studies (Ling-Ling 
et al., 1992; Pieper et al., 1994; Rafferty et al., 1994). 
These studies, in addition to the presence of highly 
conserved or invariant aa surrounding the cysteine acceptor 
site, suggest that an understanding of MGMT aa required for 
activity and substrate specificity requires an analysis of aa 
beyond those directly involved in alkyl group transfer. The 
studies in this dissertation were therefore designed to 
systematically analyze the role of aa regions in protein 
function by generating a series of MGMT and Ada chimeric 
proteins and MGMT deletion mutants and oligopeptides, and 
examining the biochemical properties of these mutant proteins 
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including repair of 0 6 -MG and 0 4 -MT in DNA and 0 6 -BG. These 
studies have successfully identified aa regions which play a 
role in MGMT activity and substrate specificity and thus 
these studies, as a whole, have contributed to the overall 
understanding of how MGMT functions. The interpretation and 
significance of these findings are discussed below. 
Several experiments described in this dissertation 
indicate that aa located throughout nearly the entire protein 
are involved in MGMT-mediated DNA repair activity. With 
regard to the MGMT oligopeptide study, the inability of the 
MGMT PCHRV-containing oligopeptides to repair 0 6 -MG in DNA 
suggests that the highly conserved 22 aa immediately 
surrounding the PCHRV acceptor site alone are insufficient 
for 0 6 -MG repair. This finding is in agreement with recent 
studies on the Ada crystal structure which suggest that a 
larger, highly conserved 36 aa region spanning from 
asparagine 138 to glutamic acid 173 surrounding the PCHRV 
acceptor site plays a direct role in the formation of the 
protein's active site (Moore et al., 1994). In this region, 
there exist four absolutely conserved aa that are involved in 
direct or indirect hydrogen bonding to the acceptor cysteine. 
This region of the protein is thus believed to properly form, 
stabilize, and position the acceptor cysteine for 
nucleophilic attack and removal of alkyl lesions from the 0 6 -
position of guanine in DNA. This 36 aa region, however, 
still constitutes only a portion of the core sequences 
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required for alkyltransferase activity as the MGMT-Nl8, MGMT-
N78, and MGMT-C35 deletion mutants were also unable to repair 
0 6 -MG in DNA. Although these truncated GST-MGMT fusion 
proteins were non-functional, truncation of MGMT did not 
appear to affect protein expression or stability since all 
purified deletion mutants were expressed to levels comparable 
to the wild type protein and were of the predicted size as 
demonstrated by SDS-PAGE analysis. Combined data based on 
the inactive MGMT oligopeptides and MGMT deletion proteins 
therefore suggest that 0 6 -MG repair in DNA requires nearly 
the entire protein. Interestingly, based on the Ada crystal 
structure, there exists a highly conserved 85 aa carboxyl-
terminal structural domain while the remaining amino-terminal 
88 aa of Ada comprise a second structural domain which is 
relatively non-conserved between alkyltransferases (Moore et 
al., 1994). One may thus propose initially that these two 
structurally independent regions may also be functionally 
independent domains. MGMT-N78, which lacks nearly the entire 
amino-terminal structural domain, however, does not repair 
0 6 -MG in DNA, suggesting that the proposed structural regions 
are not functionally independent. Additional aa regions 
needed for protein activity, therefore, include sequences 
from both the amino- and carboxyl-terminal regions. 
While studies of MGMT oligopeptides and deletion 
proteins suggest that nearly the entire MGMT protein may be 
required for the repair of 0 6 -MG containing DNA, the 
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possibility exists that these same proteins retain the 
capacity to repair 0 6 -MG in DNA, but do so less efficiently 
as a consequence of loss of sequences required for MGMT-DNA 
interaction prior to DNA repair. The mutant proteins were, 
however, also incapable of repairing the free base 0 6 -BG. 
The inability of the MGMT oligopeptides and deletion proteins 
to repair 0 6 -MG in DNA and 0 6 -BG suggests that, as discussed 
above, nearly the entire protein is required for MGMT-
mediated DNA repair activity. Alternatively, pertaining to 
MGMT-DNA interaction, these data may also indirectly suggest 
that MGMT does not contain a separate DNA binding domain 
independent of a domain required for alkyltransferase 
activity since the MGMT truncated fusion proteins and 
oligopeptides were shown to not only lose the ability to 
repair damaged guanine in the context of DNA but also the 
ability to repair damaged guanine as a free base. Further 
understanding of how MGMT and its active site may interact 
with DNA can be derived from studies on the Ada crystal 
structure which suggest that the proposed 85 aa carboxyl-
terminal structural domain, containing the cysteine acceptor 
site, constitutes in part a helix-turn-helix (HTH) DNA-
binding motif. This putative HTH motif is proposed, but not 
proven, to be essential for the interaction of the protein 
with duplex DNA (Moore et al., 1994). DNA interaction may be 
important for MGMT activity since this proposed binding is 
believed to induce a conformational change in the protein, as 
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monitored by circular dichroism and fluorescence analyses 
( Chan et al., 1993) . This conformational change may_ be 
needed to properly orient the cysteine for nucleophilic 
attack on target alkyl groups. Indeed, the rate determining 
step in the transfer of alkyl groups to MGMT molecules has 
been suggested to be DNA binding (Chan et al., 1994; 
Takahashi et al., 1990) . The interaction of MGMT with duplex 
DNA may also be required to induce a conformational change in 
the 0 6 -MG-containing DNA substrate. Evidence of protein-
induced structural distortion of DNA substrates comes from 
studies on the recently cocrystallized structure of a DNA 
cytosine-5-methyltransferase bound covalently to DNA 
(Klimasauskas et al., 1994). In this structure, the cytosine 
residue, acting as substrate, has swung completely out of the 
DNA helix and is positioned in the active site of the protein 
which itself has undergone a conformational change. This co-
crystal structure illustrates a novel mechanism as to how the 
active site of the protein can reach its target DNA 
substrate. Given the fact that the Ada crystal structure 
reveals a concave active site containing a deeply buried 
acceptor cysteine, such structural distortion of 0 6 -MG-
containing DNA by alkyltransferases may also apply. To 
further understand MGMT-DNA binding interactions, however, 
additional structural studies on stable protein-bound 
complexes with 0 6 -MG-containing DNA are needed. Because the 
rate of repair of 0 6 -MG in DNA by the wildtype MGMT is 
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extremely fast, the design of mutant MGMT proteins that bind 
DNA but do not carry out the transfer reaction would greatly 
facilitate these studies. 
Although the studies described above indicate that MGMT 
is comprised of a single protein domain responsible for 
repair of 0 6 -MG-containing DNA, the possibility still remains 
that MGMT may be a multi-functional protein mediating non-
repair related activities. Such activities may be mediated 
by the MGMT 28 aa carboxyl-terminal tail given the tail's 
evolutionary sequence conservation among human, rat, mouse, 
and hamster alkyltransferases and the tail's dispensability 
in 0 6 -MG repair. Specifically, studies in this dissertation 
and elsewhere (Elder et al., 1992) have demonstrated that up 
to 28 aa at the carboxyl-terminus can be deleted without loss 
of alkyl transf erase activity. Furthermore, the rates of 
repair of 0 6 -MG in DNA mediated by the full-length MGMT and 
mutant MGMT-C28 were equivalent. While analysis of several 
unrelated proteins has also suggested that not all aa are 
required for intrinsic protein activity (Alber et al., 1988; 
Lim and Sauer, 1991; Morris and Wool, 1992), it remains 
unclear why a nonessential sequence such as the carboxyl-
terminal MGMT tail should evolve and be conserved among 
higher organisms. One possibility, as mentioned above, is 
that this tail is a separate functional domain that mediates 
an activity completely unrelated to DNA repair. A similar 61 
aa amino-terminal region in the human AP endonuclease 1 
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(HAPl), was recently reported to be dispensable for DNA 
repair function, but was essential for regulation of the DNA 
binding activity of the c-jun proto-oncogene product 
(Xanthoudakis et al., 1992; Walker et al., 1993; Xanthoudakis 
et al., 1994) The possibility exists that MGMT may also 
contain two nonoverlapping domains encoding distinct 
functions. Alternatively, the 28 aa carboxyl-terminal tail 
may have no significant role in protein function primarily 
since not all mammalian proteins, such as the recently 
isolated rabbit alkyltransferase (Iyama et al., 1994), 
contain this tail. The carboxyl-terminal tail does, however, 
appear to affect MGMT activity at lower temperatures since 
deletion of the tail reversibly inhibits the ability of MGMT 
to repair 0 6 -MG in DNA at 4°C. The relevance of this 
observation to MGMT-mediated repair at physiological 
conditions remains uncertain, although the data support the 
idea that the tail sequence may be involved in maintenance of 
protein folding or stability. Further biochemical analysis 
of the MGMT 28 aa carboxyl-terminal tail and MGMT deletion 
mutants may be of use in assessing alternate MGMT functions. 
While analysis of aa involved in MGMT-mediated repair of 
0 6 -MG in DNA contributes to a better understanding of how all 
alkyltransferases function, an understanding of how MGMT and 
Ada differentially interact with various lesions such as 0 6 -
BG and 0 4 -MT in DNA is lacking. Differences in MGMT and Ada 
substrate specificity may be accounted for by a common 
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limited number of aa changes which allow MGMT to repair 0 6 -BG 
but not 0 4 -MT. In the simplest sense, a single aa change in 
MGMT might allow 0 6 -BG repair yet preclude 04 -MT repair. 
Alternatively, MGMT and Ada may differ significantly in the 
overall conformation of their active sites such that 
different aa regions account for MGMT-mediated repair of 0 6 -
BG and Ada-mediated repair of 0 4 -MT. This dissertation 
addressed both possibilities by assessing the ability of MGMT 
and Ada chimeric proteins to repair 0 4 -MT in DNA and 0 6 -BG. 
The assessment of 0 6 -MG, 0 6 -BG, and 0 4 -MT repair 
capacities by MGMT and Ada chimeric fusion proteins was 
instructional in identifying critical MGMT and Ada aa regions 
involved not only in substrate specificity but also in 
protein activity. With regard to protein activity, the 
chimeric proteins MGMT-PCHRV-ADA and ADA-PCHRV-MGMT repaired 
0 6 -MG in DNA, suggesting that while MGMT and Ada differ in 
their evolutionary backgrounds, the protein conformation 
which mediates 0 6 -MG repair is comparable or at least 
complementary in both proteins. Although these studies were 
carried out using GST-chimeric fusion proteins, the full-
length GST-MGMT protein exhibited DNA repair properties 
comparable to that of endogenous MGMT in HT-29 colon 
carcinoma cell extracts, suggesting that fusion of the GST 
peptide to MGMT does not appear to affect alkyltransferase 
activity. Additionally, based on the Ada crystal structure, 
the GST peptide appears to be fused to a proposed amino-
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terminal structural domain which is independent from the 
protein's active site. This observation suggests that _the 
GST peptide would not directly alter protein activity. As 
described earlier, the unique MGMT 28 aa carboxyl-terminal 
tail is not required for MGMT activity as demonstrated by the 
ability of the MGMT-PCHRV-ADA protein, which lacks the tail, 
to repair 0 6 -MG in DNA. A 30 aa region between the shared 
PCHRV acceptor site and the MGMT 28 aa carboxyl-terminal tail 
appears to be functionally interchangeable between Ada and 
MGMT as demonstrated by the activity of MGMT-PCHRV-ADA and 
ADA-PCHRV-MGMT fusion proteins. Combined data based on the 
X-ray crystal structure of Ada (Moore et al., 1994) and the 
active chimeric proteins fused at the acceptor site have 
highlighted the potential importance of this 30 aa region 
carboxyl-terminal to the PCHRV acceptor site in the repair of 
0 6 -MG in DNA. As this 30 aa region has been proposed to 
constitute in part a random coil that serves to swivel the 
carboxyl-terminal alpha-helix and expose both a potential DNA 
binding surface and the buried active site thiol of cysteine, 
necessity and functional interchangeability of this region 
between all alkyltransferases might be expected. In addition 
to the active chimeric proteins fused at the highly conserved 
acceptor site, the MGMT-ADA-MGMT proteins, each containing 
approximately 10-20 Ada aa in place of MGMT aa, were also 
repair proficient, suggesting that, in regions examined, 
substitution of very small MGMT aa regions with the analogous 
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Ada aa does not appear to alter the protein's tertiary 
structure in such a way that affects alkyltransferase 
activity. In contrast, the fusion of MGMT and Ada sequences 
at the amino-terminus resulted in proteins with a limited 
alkyltransferase repair capacity. This minimal repair was 
not likely due to the instability of the proteins since all 
fusion mutants were expressed to levels comparable to the 
wild type and were of the predicted size as demonstrated by 
SDS-PAGE analysis. No explanation exists as to why these 
proteins exhibited only 30% maximal repair, however, the 
highly divergent amino terminal regions of MGMT and Ada 
clearly contain non-interchangeable aa which may play a key 
role in protein activity. Furthermore, additional MGMT and 
Ada chimeric proteins, each fused at one of several regions 
throughout the entire alkyltransferase, were unable to repair 
0 6 -MG in DNA (data not shown) suggesting that, in regions 
examined, such fusions may produce perturbations in the 
chimeric protein's local secondary or tertiary structures. 
With regard to substrate specificity, the unique ability 
of MGMT to interact with 0 6 -BG appears to reside, by indirect 
analysis, in any of 49 aa spanning three MGMT aa regions 
amino-terminal to the PCHRV acceptor site (aa 42-78, 93-98, 
and 138-143) (Figure 28). The 6 aa region 138-143, is of 
particular interest primarily because other studies have 
demonstrated that a single change in a praline residue (Pl40) 
located within this region reduced the ability of MGMT to 
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repair 0 6 -BG (Crone and Pegg, 1993). This single aa change 
did not, however, render MGMT completely insensitive to 0 6 -BG 
whereas the ADA-PCHRV-MGMT protein described in this 
dissertation was completely 0 6 -BG insensitive even after 
prolonged incubation time of 30 minutes. These studies 
suggest therefore that other aa besides Pl40 may play a role 
in the formation of the MGMT active site needed for 0 6 -BG 
repair. It is interesting to note that two of the three MGMT 
aa regions involved in 0 6 -BG specificity appear to be 
proline-rich areas. Proline residues are known to constrain 
the conformation of adjacent residues which can lead to bends 
in the protein's secondary structural elements (Crone and 
Pegg, 1993) . Such bends may serve as extremely flexible 
areas of the protein which in turn may alter the overall 
protein conformation in such a way that creates an 
appropriate sized active site needed for MGMT-mediated repair 
of 0 6 -BG. 
While MGMT sequences potentially involved in 0 6 -BG 
repair include three defined aa regions amino-terminal to the 
PCHRV acceptor site, aa involved in Ada-selective repair of 
0 4 -MT are located both amino- and carboxyl-terminal to the 
PCHRV acceptor site. These studies exclude the possibility 
that a few common aa changes within MGMT and Ada can account 
for both 0 4 -MT and 0 6 -BG repair capacities. Instead, MGMT and 
Ada may differ significantly in the conformation of their 
active sites such that different aa regions within MGMT and 
Ada contribute to 
specificity. 
the protein's overall 
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substrate 
The exact mechanism by which MGMT and Ada sequences aid 
in MGMT-mediated repair of 0 6 -BG or Ada-mediated repair of 0 4 -
MT is unclear. It is possible that divergent aa may 
constitute either a well-defined aa segment that borders the 
protein's active site or, alternatively, these aa may be 
scattered throughout the protein. These scattered aa, as a 
whole, may comprise the appropriate size pocket for 
differential lesion repair. With regard to scattered aa 
involved in substrate specificity, X-ray crystallographic 
studies of dihydrofolate reductase and the human 
butyrylcholinesterase have demonstrated that a few highly 
conserved aa, spread throughout the primary protein sequence, 
can come together in a three-dimensional structure to form an 
active site (Harel et al., 1992; Dicker et al., 1993) . 
Although these essential aa were shown to be considerably 
distant from the enzyme's catalytic center, they appeared to 
affect substrate specificity by indirectly affecting the 
protein's tertiary structure and by facilitating in the 
closure of the protein's active site around the substrate. 
Such conformational changes induced by aa or aa regions, 
subsequent to protein-substrate binding, have been well 
studied (Dicker et al., 1993). Specific MGMT aa regions 42-
78, 93-98, and 138-143, as discussed above, may contain 
critical aa, not present in Ada, which play a role in 
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increasing the size of the space surrounding the acceptor 
cysteine, thereby accommodating MGMT interaction with larger 
molecules such as 0 6 -BG. The MGMT 28 aa carboxyl-terminal 
tail region may also play a role in the formation of the MGMT 
acceptor site. 
described in 
Evidence for this notion comes from studies, 
this dissertation, which demonstrated that 
removal of the tail from MGMT decreased the rate of MGMT-
mediated 0 6 -BG repair at least 5-fold, suggesting that the 
carboxyl-terminal tail indirectly affects 0 6 -BG repair 
activity. The presence of a tail may induce changes in the 
tertiary structure of the protein needed to properly form and 
orient the MGMT active site around bulkier molecules such as 
Alternatively, the tail may simply be involved in 
positioning the PCHRV acceptor site so as to allow optimal 
DNA repair. The inability of ADA-MGMTTAIL to repair 0 6 -BG, 
however, indicates that the tail alone is insufficient to 
directly alter the protein's active site in such a way as to 
facilitate 0 6 -BG repair. 
In contrast to scattered aa or aa regions playing a role 
in the formation of a unique acceptor site necessary for 
selective repair of 0 6 -BG or 04 -MT, the possibility also 
exists that MGMT and Ada, while both containing a similar 
sized active site pocket, contain a well-defined aa region 
within the active site which may confer selectivity for 0 6 -BG 
or 0 4 -MT substrates. Recent crystallographic studies of the 
Ada protein have at least indirectly suggested such an aa 
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region which may define the ability of the protein to 
recognize distinct substrates. In these studies, four_aa 
between Asn 138 and Glu 173 directly or indirectly hydrogen 
bond to the acceptor cysteine suggesting that this region of 
the protein may form the active site of the molecule (Moore 
et al., 1994) . It is therefore possible that this core 
region alone may dictate MGMT's ability to repair 0 6 -BG (and 
exclude 0 4 -MT) whereas the analogous aa region in Ada may be 
enough to confer 0 4 -MT selectivity. Discrimination between 
substrates by exclusion from the protein's acceptor site of 
the non-preferred substrate has been studied in other 
proteins (Liu and Santi, 1993). Such exclusion is a 
consequence of disruptive hydrogen bonding between specific 
aa side chain groups and the unsuitable DNA substrate. The 
concept of substrate acceptance versus exclusion may also be 
useful in understanding the action of MGMT as substrate 
specificity may reside in only a few aa selective for 
recognition and repair of 0 6 -BG. Site-directed mutagenesis 
studies of divergent MGMT and Ada aa, however, may lead to a 
better understanding of the exact mechanism by which MGMT and 
Ada sequences play a direct and/or indirect role in substrate 
specificity. 
Al though the general mechanism involving the transfer of 
alkyl groups from the 0 6 -position of guanine to a cysteine 
contained within the alkyltransferase's PCHRV acceptor site 
is known, very little else is understood about how regions of 
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the MGMT primary aa sequence contribute to alkyltransferase 
stability, activity, and substrate specificity. The studies 
described in this dissertation suggest that nearly all aa 
contribute to MGMT-mediated repair of 0 6 -MG in DNA. The 
unique MGMT 28 aa carboxyl-terminal tail, however, was not 
required for the repair of 0 6 -MG in DNA or 0 6 -BG although 
deletion of the tail reversibly inhibited the ability of MGMT 
to repair 0 6 -MG-containing DNA at lower temperatures. With 
regard to substrate specificity, the unique ability of MGMT 
to interact with 0 6 -BG appears to reside in any of 49 aa 
spanning three MGMT aa regions amino-terminal to the PCHRV 
acceptor site. From these conclusions, one can suggest that 
MGMT is most likely a single domain protein, perhaps 
requiring most of its aa sequences for proper protein 
folding, DNA interaction, and activity, while select MGMT aa, 
that are either necessary or dispensable for protein 
activity, may play a vital role in conferring DNA substrate 
specificity. 
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